{
    "paper_id": "fec3341ef764994cddf6a0a2ed49029ba2305142",
    "metadata": {
        "title": "Kutane Lymphome 3.1 Arten und Diagnostik Prim\u00e4r kutaner T-Zell-Lym phome (CTCL) -139",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Kutane Lymphome (cutaneous lymphomas: CL) umfassen die Gruppe der kutanen T-Zell-Lymphome (cutaneous T-cell lymphomas: CTCL), kutanen B-Zell-Lymphome (cutaneous B-cell lymphomas: CBCL) und die sog. h\u00e4matodermischen Neoplasien (HN). CL geh\u00f6ren zur Gruppe der Non-Hodgkin-Lymphome (NHL) und stellen in der Subgruppe der extranodalen NHL die zweith\u00e4ufigste Gruppe hinter den gastrointestinalen Lymphomen dar (Jaffe et al. 2009 ). Man unterscheidet zwischen prim\u00e4ren und sekund\u00e4ren CL. Prim\u00e4re CL haben ihren Ursprung in der Haut und bleiben in der Regel darauf auch l\u00e4ngere Zeit beschr\u00e4nkt, w\u00e4hrend sekund\u00e4re CL kutane Manifestationen von prim\u00e4r nodalen oder extranodalen Lymphomen darstellen . Die prim\u00e4ren CL unterscheiden sich hinsichtlich klinischem Verlauf, Therapieoptionen und Prognose erheblich von nodalen und extrakutanen Lymphomen. So zeigen z. B. die prim\u00e4r kutanen CD30 + -T-Zell-Lymphome einen gutartigen Verlauf, wogegen die nodalen Varianten als aggressiv eingestuft werden. Da die CL zumeist weniger aggressiv sind, werden sie auch weniger aggressiv behandelt. Prim\u00e4re CL stellen eine morphologisch und histologisch heterogene Gruppe lymphoproliferativer Neoplasien dar, die sich durch das klinische Verhalten und die Prognose teils erheblich voneinander unterscheiden. Unterschiedliche Nomenklaturen und Klassifikationen wurden 2005 in einer gemeinsamen WHO-EORTC-Klassifikation vereinheitlicht, die gutartige sowie aggressive Lymphome nicht nur anhand der Zytomorphologie, sondern auch anhand des klinischen Verlaufs differenziert Slater et al. 2005) . Etwa 95% der CL lassen sich damit erfassen. Die gr\u00f6\u00dfte Gruppe stellen dabei die spezifizierten CTCL mit 65% der F\u00e4lle dar, 25% machen die CBCL aus und 10% die Gruppe der nichtspezifizierten CTCL sowie der h\u00e4matodermischen Neoplasien (HN; Assaf et al. 2007a; Stadler et al. 2008) . CTCL entwickeln sich durch Proliferation klonaler T-Lymphozytenje nach Lymphomtyp T-Helferzellen, Killerzel-len oder zytotoxische T-Zellen (. Tab. 3.1) -, CBCL aus klonalen B-Lymphozyten, die dann in der Haut akkumulieren. Die CD4 + /CD56 + -HN gehen von plasmozytoiden dendritischen Zellen aus. Die Inzidenz kutaner Lymphome wird mit etwa 1 Neuerkrankung pro 100.000 Einwohner und Jahr angegeben (Weinstock 1994) . Bei den CTCL sind es 0,6/100.000 bei den M\u00e4nnern und 0,3/100.000 bei den Frauen; bei CBCL sind es 0,4/100.000 bei den M\u00e4nnern und 0,3/100.000 bei den Frauen. Seit den 1970er Jahren fand sich zun\u00e4chst eine deutliche Zunahme der Inzidenz von malignen NHL, im Gegensatz zu den Hodgkin-Lymphomen, und zwar um j\u00e4hrlich 4,2%. Dabei war die Zunahme deutlicher bei den extranodalen als bei nodalen Lymphomen. Als urs\u00e4chlich scheinen im Wesentlichen alterungsbedingte Prozesse, z. B. chromosomale Mutationen, chronische Infektionen oder Kanzerogene eine Rolle zu spielen. Eine k\u00fcrzlich durchgef\u00fchrte Analyse durch das National Cancer Institute der USA (NCI) zeigte, dass die Inzidenzrate der Mycosis fungoides seit 1995 stabil blieb, nach einem Anstieg in den Jahren zuvor, was auf eine Verbesserung der diagnostischen Genauigkeit zur\u00fcckgef\u00fchrt wurde (Korgavkar et al. 2013 ).",
            "cite_spans": [
                {
                    "start": 405,
                    "end": 423,
                    "text": "(Jaffe et al. 2009",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 1547,
                    "end": 1566,
                    "text": "Slater et al. 2005)",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 1807,
                    "end": 1826,
                    "text": "Assaf et al. 2007a;",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1827,
                    "end": 1847,
                    "text": "Stadler et al. 2008)",
                    "ref_id": null
                },
                {
                    "start": 2247,
                    "end": 2263,
                    "text": "(Weinstock 1994)",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 3108,
                    "end": 3130,
                    "text": "(Korgavkar et al. 2013",
                    "ref_id": "BIBREF53"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "j Therapieziel",
            "cite_spans": [],
            "ref_spans": [],
            "section": "WHO-EORTC-Klassifikation der kutanen"
        },
        {
            "text": "Da die CTCL in der Regel \u00fcber lange Zeit wenig aggressiv verlaufen, sehr selten zum Tod f\u00fchren, die Patienten meist \u00e4lter sind und kurative Therapien nicht zur Verf\u00fcgung stehen, ist es das Therapieziel l\u00e4ngere Remissionen zu erzielen bei optimaler Erhaltung der Lebensqualit\u00e4t. Eine fr\u00fche aggressive Therapie bei einem wenig aggressiven Lymphom erh\u00f6ht weder die Ansprechrate noch das Gesamt\u00fcberleben. Da aufgrund der Lymphomerkrankung bei den meisten Patienten eine Immunsuppression vorliegt, sollten zytotoxische Therapien (die sich auch auf gesunde Lymphozyten auswirken) m\u00f6glichst zur\u00fcckhaltend eingesetzt werden. Es gilt, das Ungleichgewicht der sich zunehmend entwickelnden T-Helfer 2 (Th2)-Immunantwort in Richtung einer Th1-dominierten zu \u00fcberf\u00fchren.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "WHO-EORTC-Klassifikation der kutanen"
        },
        {
            "text": "Innerhalb der prim\u00e4r kutanen CTCL unterscheidet man zwischen Mycosis fungoides (MF) -mit den Sonderformen follikulotrope MF, pagetoide Retikulose und granulomatous slack skin -, dem S\u00e9zary-Syndrom, den CD30 + -Lymphomen und seltenen Entit\u00e4ten.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Arten und Diagnostik Prim\u00e4r kutaner T-Zell-Lymphome (CTCL)"
        },
        {
            "text": "j Epidemiologie",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Mycosis fungoides (MF)"
        },
        {
            "text": "H\u00e4ufigstes CTCL: macht fast 50% aller CTCL aus; Auftreten \u226550. Lebensjahr (Median 55-60 Jahre, m>w (m:w = 1,6-2:1). (Zackheim et al. 1998 ). Topische Reti no ide/Rexinoide (Bexarotengel) k\u00f6nnen f\u00fcr Einzell\u00e4sionen und in seltenen F\u00e4llen von CTCL im jugendlichen Alter verwendet werden (Farol u. Hymes 2004) . Topisches Mechlorethamine (Senfgas) oder Chlormustine (BCNU) wird heute seltener eingesetzt. Zun\u00e4chst wird PUVA (vorzugsweise orale PUVA; Bade-PUVA in den F\u00e4llen, in denen der Kopf nicht betroffen ist) und, wenn nicht ausreichend, PUVA in Kombination mit Inter feron-\u03b1 (IFN-\u03b1) oder Retinoiden (Isotretinoin, Acitretin)/ Rexinoiden (Bexaroten) eingesetzt. Wenn die Erkrankung progredient ist, kann mit PUVA + IFN-\u03b1 + Retinoiden behandelt werden oder mit PUVA + Methotrexat (MTX) in Kombination mit entweder IFN-\u03b1 oder Retinoiden (Dummer et al. 1996a) . Die Ansprechrate von PUVA versus PUVA + IFN-\u03b1 oder PUVA + Retinoid ist vergleichbar hoch (42-80%), somit zeigen Kombinationstherapien keine h\u00f6heren Ansprechraten. In der Kombination wurden jedoch signifikant geringere UVA-Dosen bis zur Remission ben\u00f6tigt und es fanden sich signifikant verl\u00e4ngerte Remissionszeiten im Vergleich zur Monotherapie (Roenigk et al. 1990 , Humme et al. 2014 . IFN-\u03b1 erh\u00f6ht demnach nicht die Remissionsrate, f\u00fchrt aber zu einer rascheren Abheilung und einer Verdopplung der rezidivfreien Zeit (Trautinger et al. 2006 (Humme et al. 2014) . Eine weitere Therapie option ist PUVA + IFN-\u03b1 in Kombination mit R\u00f6ntgenweichstrahltherapie (6-8\u00d7 200 cGY, 50 kV, 2\u00d7 w\u00f6-chentlich; H\u00f6nigsmann et al. 1984; Kuzel et al. 1995; Dummer et al. 1996a; Jones et al. 1999) .",
            "cite_spans": [
                {
                    "start": 116,
                    "end": 137,
                    "text": "(Zackheim et al. 1998",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 284,
                    "end": 305,
                    "text": "(Farol u. Hymes 2004)",
                    "ref_id": null
                },
                {
                    "start": 836,
                    "end": 857,
                    "text": "(Dummer et al. 1996a)",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 1205,
                    "end": 1225,
                    "text": "(Roenigk et al. 1990",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 1226,
                    "end": 1245,
                    "text": ", Humme et al. 2014",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1380,
                    "end": 1403,
                    "text": "(Trautinger et al. 2006",
                    "ref_id": null
                },
                {
                    "start": 1404,
                    "end": 1423,
                    "text": "(Humme et al. 2014)",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1557,
                    "end": 1580,
                    "text": "H\u00f6nigsmann et al. 1984;",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 1581,
                    "end": 1599,
                    "text": "Kuzel et al. 1995;",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 1600,
                    "end": 1620,
                    "text": "Dummer et al. 1996a;",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 1621,
                    "end": 1639,
                    "text": "Jones et al. 1999)",
                    "ref_id": "BIBREF45"
                }
            ],
            "ref_spans": [],
            "section": "Mycosis fungoides (MF)"
        },
        {
            "text": "Im Stadium III ist die extrakorporale Photopherese (ECP; 7 Abschn. 3.1.10) ein weiterer gut vertr\u00e4glicher Therapieansatz, der mit IFN-\u03b1, MTX oder Retinoiden kombiniert werden kann (Knobler et Girardi et al. 2001; Olsen et al. 2011) . Bei Progredienz sollte eine Chemotherapie erfolgen mit Gemcitabin, dem Knospe-Schema (Prednison + Chlorambucil; Lan sigan et al. 2010) oder -wenn hierauf kein Ansprechenmit CHOP-Polychemotherapie (Fierro et al. 1998; 7 Abschn. 3.2.22) . Die Radiotherapie stellt eine Alternative und Erg\u00e4nzung dar.",
            "cite_spans": [
                {
                    "start": 180,
                    "end": 212,
                    "text": "(Knobler et Girardi et al. 2001;",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 213,
                    "end": 231,
                    "text": "Olsen et al. 2011)",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 305,
                    "end": 345,
                    "text": "Knospe-Schema (Prednison + Chlorambucil;",
                    "ref_id": null
                },
                {
                    "start": 346,
                    "end": 368,
                    "text": "Lan sigan et al. 2010)",
                    "ref_id": null
                },
                {
                    "start": 430,
                    "end": 450,
                    "text": "(Fierro et al. 1998;",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 451,
                    "end": 468,
                    "text": "7 Abschn. 3.2.22)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Mycosis fungoides (MF)"
        },
        {
            "text": "Das Retinoid-X-Rezeptor-spezifische Retinoid Bexaroten (Targretin \u00ae ) kann \u00fcber alle Stadien des CTCL als Monotherapeutikum eingesetzt werden mit Ansprechraten bis zu 50%. \u00c4hnlich den \u00e4lteren Retinoiden setzt die Wirkung mit zeitlichem Verzug ein. Bexaroten wird in einer Dosierung von 300 mg/m 2 /d als Monosubstanz eingesetzt, aber auch deutlich gerin gere Dosen (150 mg/m 2 /d) sind nach ersten Erfahrungen als effektiv anzusehen (Scarisbrick et al. 2013) . Da dieses Molek\u00fcl durch Heterodimerbildung den Lipid-und Schilddr\u00fcsenstoffwechsel beeinflusst, ist eine initiale Begleitmedikation mit einem Fibrat und L-Thyroxin-Substitution zwingend erforderlich (Duvic et al. 2001a,b; Abbott, et al. 2009; 7 Abschn. 3.1.10). Bexaroten wurde in der Therapie der kutanen Lymphome in Kombination mit PUVA, extrakorporaler Photopherese, IFN-\u03b1, MTX und Denileukin diftitox eingesetzt (Duvic et al. 2001a ,b, Farol u. Hymes et al. 2004 , Kannangara et al. 2009 , Humme et al. 2014 . W\u00e4hrend PUVA und IFN-\u03b1 in der Kombina tionstherapie mit Bexaroten keine signifikante Erh\u00f6hung der Ansprechrate und -dauer im Vergleich zur Monotherapie zeigten (Straus et al. 2007; Whittaker et al. 2012) , scheint ins besondere MTX den Effekt von Bexaroten zu erh\u00f6hen (Duvic et al. 2001a,b (Duvic et al. 2001a,b) .",
            "cite_spans": [
                {
                    "start": 433,
                    "end": 458,
                    "text": "(Scarisbrick et al. 2013)",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 659,
                    "end": 681,
                    "text": "(Duvic et al. 2001a,b;",
                    "ref_id": null
                },
                {
                    "start": 682,
                    "end": 702,
                    "text": "Abbott, et al. 2009;",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 703,
                    "end": 704,
                    "text": "7",
                    "ref_id": null
                },
                {
                    "start": 876,
                    "end": 895,
                    "text": "(Duvic et al. 2001a",
                    "ref_id": null
                },
                {
                    "start": 896,
                    "end": 926,
                    "text": ",b, Farol u. Hymes et al. 2004",
                    "ref_id": null
                },
                {
                    "start": 927,
                    "end": 951,
                    "text": ", Kannangara et al. 2009",
                    "ref_id": null
                },
                {
                    "start": 952,
                    "end": 971,
                    "text": ", Humme et al. 2014",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1134,
                    "end": 1154,
                    "text": "(Straus et al. 2007;",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 1155,
                    "end": 1177,
                    "text": "Whittaker et al. 2012)",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 1242,
                    "end": 1263,
                    "text": "(Duvic et al. 2001a,b",
                    "ref_id": null
                },
                {
                    "start": 1264,
                    "end": 1286,
                    "text": "(Duvic et al. 2001a,b)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Mycosis fungoides (MF)"
        },
        {
            "text": "(Caelyx \u00ae , Myocet \u00ae ) wird in einer Dosierung von 20 mg/m 2 14-t\u00e4gig i.v. appliziert und zeigte in einer retrospektiven Multicenterstudie Ansprechraten von 41-80% und eine mittlere Ansprechdauer von 6 Monaten (Wollina et al. 2003; . In fortgeschrittenen Tumorstadien kann hiermit auch ein sog. Debulking erfolgen. Hierzu wird 14-t\u00e4gig zwei-bis dreimal liposomal verkapseltes Doxorubicin infundiert, um nachfolgend mit PUVA oder Bexaroten als Erhaltungstherapie fortzufahren (Wollina et al. 2001; Dummer et al. 2007 ). Brentuximab Vedotin (Adcetris \u00ae ) ist ein Antik\u00f6rper-Wirkstoff-Konjugat, welches einen monoklonalen anti-CD30-Antik\u00f6rper enth\u00e4lt, der kovalent an Molek\u00fcle des Zytostatikums Monomethylauristatin E, einem Mikrotubuli-Destabilisator, gebunden ist. Es ist zugelassen f\u00fcr die Behandlung des CD30 + Non-Hodgkin-Lymphoms, des systemischen anaplastischen gro\u00dfzelligen Lymphoms (sALCL) sowie bei CD30+ kutanen T-Zell-Lymphomen (CTCL) nach mindestens einer vorangegangenen systemischen Behandlung (Thomas et al. 2016) . Bei MF/SS-Patienten mit starker CD 30-Positivit\u00e4t konnten Ansprechraten von 70% gezeigt werden (Prince et al. 2017) . Dosislimi tierende Hauptnebenwirkungen zeigten sich in einer peripheren Neuropathie und Neutropenie.",
            "cite_spans": [
                {
                    "start": 210,
                    "end": 231,
                    "text": "(Wollina et al. 2003;",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 475,
                    "end": 496,
                    "text": "(Wollina et al. 2001;",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 497,
                    "end": 515,
                    "text": "Dummer et al. 2007",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1006,
                    "end": 1026,
                    "text": "(Thomas et al. 2016)",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 1124,
                    "end": 1144,
                    "text": "(Prince et al. 2017)",
                    "ref_id": "BIBREF74"
                }
            ],
            "ref_spans": [],
            "section": "Liposomal verkapseltes Doxorubicin"
        },
        {
            "text": "Mogamulizumab, ein humanisierter monoklonaler Antik\u00f6rper gegen den CC-Chemokin-Rezeptor 4 (CCR4), der auf malignen T-Lymphozyten \u00fcberexprimiert wird und deren Extravasation in die Haut unterst\u00fctzt. Durch Aktivierung von NK-Zellen wird die Zerst\u00f6rung maligner T-Zellen bewirkt. Mogamulizumab wurde f\u00fcr die Behandlung the rapie refrakt\u00e4rer CCR4+ peripherer T-Zell-Lymphome und CTCL zugelassen und zeigte in Studien Gesamtansprechraten zwischen 29% (MF) und 47% (SS), insbesondere in leuk\u00e4mischen Varianten. Es wird in einer Dosierung von 1 mg/kg KG i.v. 1\u00d7 w\u00f6chentlich in den ersten 4 Wochen, dann alle 2 Wochen eingesetzt. Neben wir kungen waren geringgradig und zeigten sich in Fieber, \u00dcbelkeit und Kopfschmerzen (Duvic et al. 2015 , Zinzani et al. 2016 (Foss et al. 2005) .",
            "cite_spans": [
                {
                    "start": 713,
                    "end": 731,
                    "text": "(Duvic et al. 2015",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 732,
                    "end": 753,
                    "text": ", Zinzani et al. 2016",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 754,
                    "end": 772,
                    "text": "(Foss et al. 2005)",
                    "ref_id": "BIBREF30"
                }
            ],
            "ref_spans": [],
            "section": "Liposomal verkapseltes Doxorubicin"
        },
        {
            "text": "Mit Alemtuzumab (MacCampath \u00ae ; 7 Abschn. 3.1.10), einem gegen das Zelloberfl\u00e4chenglycoprotein -CD52 auf B-und T-Lymphozyten gerichteten Antik\u00f6rper, wurden Gesamtansprechraten von mehr als 50% erreicht (Lundin et al. 2003) . Es wird in der Standarddosierung von 30 mg i.v. dreimal w\u00f6chentlich eingesetzt. Alemtuzumab scheint vor allem bei Patienten mit Erythrodermie (T4) und Blutbeteiligung (B2) vorteilhaft und hat hier in Einzelf\u00e4llen auch Langzeitremission gezeigt, wobei Im munsuppression mit Auftreten opportunistischer Infektionen die h\u00e4ufigste und schwer wiegendste Nebenwirkung darstellte (de Masson et al. 2014) . In ersten Low-dose-Therapieregimes konnte die Anwendung von 15 mg s.c. jeden 2. Tag \u00e4hnliche Ansprechraten bei reduzierter Toxizit\u00e4t zeigen ). Das Medikament wurde 2012 f\u00fcr die Indikation chronisch lymphatische Leuk\u00e4mie vom Markt genommen, kann jedoch \u00fcber den Hersteller bezogen werden (Sanofi Genzyme). Es ist jetzt unter dem Han dels namen Lemtrada \u00ae f\u00fcr die Indikation Multiple Sklerose erh\u00e4ltlich.",
            "cite_spans": [
                {
                    "start": 202,
                    "end": 222,
                    "text": "(Lundin et al. 2003)",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 598,
                    "end": 621,
                    "text": "(de Masson et al. 2014)",
                    "ref_id": "BIBREF16"
                }
            ],
            "ref_spans": [],
            "section": "Liposomal verkapseltes Doxorubicin"
        },
        {
            "text": "In Erprobung befindliche Therapeutika Im Stadium III der MF sowie beim S\u00e9zary-Syndrom haben sich Purinanaloga (Pentostatin), die nicht in den Leitlinien integriert sind, als Monochemotherapeutika bew\u00e4hrt. Pentostatin (Nipent \u00ae ) ist zur Therapie der Haarzell-Leuk\u00e4mie zugelassen. Es wird \u00fcber Ansprechraten von bis zu 60% bei einer Dosierung von 5 mg/m 2 i.v. \u00fcber 3 Tage berichtet (Foss et al. 2003) . Vorinostat (Zolinza \u00ae ; 7 Abschn. 3.1.10), ein Histondeacetylaseinhibitor, wurde Ende 2006 f\u00fcr die Therapie des kutanen T-Zell-Lymphoms in den USA zugelassen (Mann et al. 2007; Kavanaugh et al. 2010) , die Zulassung wurde jedoch wieder zur\u00fcckgezogen, da ein etwaiger Nutzen die festgestellten Risiken (Thrombozytopenien als auch in Einzelf\u00e4llen thromboembolische Komplikationen) nicht \u00fcberwog.",
            "cite_spans": [
                {
                    "start": 382,
                    "end": 400,
                    "text": "(Foss et al. 2003)",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 561,
                    "end": 579,
                    "text": "(Mann et al. 2007;",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 580,
                    "end": 602,
                    "text": "Kavanaugh et al. 2010)",
                    "ref_id": "BIBREF46"
                }
            ],
            "ref_spans": [],
            "section": "Liposomal verkapseltes Doxorubicin"
        },
        {
            "text": "Bortezomib, ein Proteasom-Inhibitor (7 Abschn. 3.1.10), ist f\u00fcr das multiple Myelom zugelassen und wird bei CTCL erprobt. In einer kleinen Studie zeigte sich eine Ansprechrate von 67% bei moderater Vertr\u00e4glichkeit mit dem Auftreten von Leukopenien, Thrombopenien und Neuropathien (Zinzani et al. 2006 Durch eine Zerst\u00f6rung der elastischen Fasern kommt es v. a. im Bereich der Achseln und Leisten zu Cutis-laxa-artigen schlaffen Hautfalten. Das gleiche klinische Bild kann sich auch bei Patienten mit bereits bestehender MF entwickeln. Der Verlauf ist langsam progredient, insgesamt eher benigne, ein extrakutaner Befall ist selten. Die Prognose ist prinzipiell gut, wird jedoch durch das Auftreten von Zweitlymphomen (in 1/3 der F\u00e4lle, zumeist Hodgkin-Lymphome) beeinflusst.",
            "cite_spans": [
                {
                    "start": 280,
                    "end": 300,
                    "text": "(Zinzani et al. 2006",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Liposomal verkapseltes Doxorubicin"
        },
        {
            "text": "j Therapie",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Liposomal verkapseltes Doxorubicin"
        },
        {
            "text": "R\u00f6ntgenweichstrahlen. Nach Exzision rasche Rezidive.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Liposomal verkapseltes Doxorubicin"
        },
        {
            "text": "Das S\u00e9zary-Syndrom (SS) wird oft als leuk\u00e4mische Variante der MF bezeichnet. Knospe et al. 1974; Coors et al. 2000) . Beim Knospe-Schema sollten die Therapiezyklen 3\u00d7 2-w\u00f6chentlich, 3\u00d7 3-w\u00f6chentlich und dann 4-w\u00f6chentlich erfolgen. Ein Ansprechen kann mit gewisser Latenz erfolgen. In Abh\u00e4ngigkeit vom klinischen Verlauf k\u00f6nnen die Intervalle weiter ausgedehnt werden. Zus\u00e4tzlich kann die Therapie durch eine klassische PUVA-Therapie \u00b1 IFN-\u03b1 \u00b1 ECP erg\u00e4nzt werden. Viele Studien zur Therapie des S\u00e9zary-Syndroms beinhalten keine pr\u00e4zisen Angaben zur Diagnostik und Stadieneinteilung, was einen Vergleich der therapeutischen Optionen erschwert (Evidenzlevel IV).",
            "cite_spans": [
                {
                    "start": 77,
                    "end": 96,
                    "text": "Knospe et al. 1974;",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 97,
                    "end": 115,
                    "text": "Coors et al. 2000)",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [],
            "section": "S\u00e9zary-Syndrom"
        },
        {
            "text": "Unter dieser Gruppe werden das CD30 + -anaplastisch gro\u00dfzellige Lymphom und die lymphomatoide Papulose zusammengefasst, die mit zusammen 30% die zweith\u00e4ufigste Gruppe unter den CTCL darstellen. Sie sind charakterisiert durch das Kommen und Gehen der Hautver\u00e4nderungen und durch eine gute Prognose. Histologische Kriterien allein sind h\u00e4ufig nicht ausreichend, um zwischen den Varianten zu unterscheiden.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane CD30 +lymphoproliferative Erkrankungen"
        },
        {
            "text": "Typischerweise beim Erwachsenen, vorwiegend bei M\u00e4nnern.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CD30 + -prim\u00e4r kutanes anaplastisches gro\u00dfzelliges Lymphom (PC-ALCL) j Epidemiologie"
        },
        {
            "text": "j Klinik",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CD30 + -prim\u00e4r kutanes anaplastisches gro\u00dfzelliges Lymphom (PC-ALCL) j Epidemiologie"
        },
        {
            "text": "Meist einzelne oder gruppierte, oft ulzerierte Knoten von 1-15 cm Durchmesser in einem anatomischen Areal, selten multifokale Ausbreitung (20%), spontane Regression bei 40% der Patienten, die typischerweise mit einer Narbenbildung verbunden ist (. Abb. 3.4). Extrakutane Beteiligung in 10% der F\u00e4lle, meist in Form von Lymphknotenbefall, welcher aber nicht mit einer ung\u00fcnstigeren Prognose verbunden ist (Bekkenk et al. 2000) . Aktivierte T-Helfer-Zellen (CD3 + , CD4 + , CD5 + , CD30 + , CD8 -, CD15 -).",
            "cite_spans": [
                {
                    "start": 404,
                    "end": 425,
                    "text": "(Bekkenk et al. 2000)",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "CD30 + -prim\u00e4r kutanes anaplastisches gro\u00dfzelliges Lymphom (PC-ALCL) j Epidemiologie"
        },
        {
            "text": "j Therapie",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CD30 + -prim\u00e4r kutanes anaplastisches gro\u00dfzelliges Lymphom (PC-ALCL) j Epidemiologie"
        },
        {
            "text": "Je nach Schwere und Symptomatik der L\u00e4sionen; insgesamt aufgrund der Benignit\u00e4t der Erkrankung sehr zur\u00fcckhaltend -\"wait and see\"; PUVA; Low-dose-Methotrexat (5-20 mg/ Woche), Exzision schmerzhafter oder st\u00f6render L\u00e4sionen (. Tab. 3.7).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CD30 + -prim\u00e4r kutanes anaplastisches gro\u00dfzelliges Lymphom (PC-ALCL) j Epidemiologie"
        },
        {
            "text": ". Abb. 3.4a,b Prim\u00e4r kutane CD30 + -lymphoproliferative Erkrankungen. a CD30 + -prim\u00e4r kutanes anaplastisches gro\u00dfzelliges Lymphom. b Lymphomatoide Papulose",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CD30 + -prim\u00e4r kutanes anaplastisches gro\u00dfzelliges Lymphom (PC-ALCL) j Epidemiologie"
        },
        {
            "text": "Adulte T-Zell-Leuk\u00e4mie/ Lymphom (ATLL, HTLV-1 + )",
            "cite_spans": [],
            "ref_spans": [],
            "section": "3.1.7"
        },
        {
            "text": "j Epidemiologie",
            "cite_spans": [],
            "ref_spans": [],
            "section": "3.1.7"
        },
        {
            "text": "Wird durch das humane T-Zell-Leuk\u00e4mie-Virus 1 (HTLV-1) hervorgerufen. Endemisch in Japan, Afrika und in der Karibik; in Europa sehr selten. Die leuk\u00e4mischen Infiltrate sind CD3 + , CD4 + , CD8und stark CD25 + (T-Helfer-Zellen).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "3.1.7"
        },
        {
            "text": "j Therapie Polychemotherapie bei akutem und Lymphom-Typ, stadienabh\u00e4ngig beim chronischen Typ.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "3.1.7"
        },
        {
            "text": "F\u00fcr die meisten seltenen prim\u00e4ren kutanen Lymphome existieren keine gr\u00f6\u00dferen Studien und daher auch keine darauf beruhenden Therapieempfehlungen. Zudem wurden einige Entit\u00e4ten erst in den letzten Jahren erkannt und klassifiziert. Therapeutisch wurde bisher bei allen seltenen Entit\u00e4ten eine aggressive Polychemotherapie empfohlen. Allerdings sind das subkutane pannikulitisartige \u03b1/\u03b2-T-Zell-Lym phom und das prim\u00e4r kutane klein-bis mittelzellige CD4 + -pleomorphe T-Zell-Lymphom mit einer sehr guten Prognose assoziiert, so dass hier konservative bzw. milde Therapieformen indiziert erscheinen.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Seltene Entit\u00e4ten"
        },
        {
            "text": "In der aktuellen WHO-Klassifikation ) wird nur noch die klinische Manifestation mit \u03b1/\u03b2-T-Zell-Rezep tor ketten-Re kombination als subkutanes pannikulitisartiges T-Zell-Lymphom eingeordnet (SPTCL-AB, . Abb. 3.5). Diese zeigt im Gegensatz zu ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Subkutanes pannikulitisartiges \u03b1/\u03b2-T-Zell-Lymphom (SPTCL-AB)"
        },
        {
            "text": "Alle kutanen CD4 + -, CD30 --T-Zell-Lymphome mit mittelgro\u00dfen-bis gro\u00dfen meist pleomorphen oder immunoblastenartigen Zellen, die in keine andere provisorische Kategorie eingeordnet werden k\u00f6nnen.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS)"
        },
        {
            "text": "j Klinik",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS)"
        },
        {
            "text": "Es zeigen sich zumeist generalisierte Plaques oder Knoten, oft systemischer Befall.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS)"
        },
        {
            "text": "j Prognose",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS)"
        },
        {
            "text": "Die Prognose ist schlecht mit einer 5-Jahres-\u00dcberlebensrate <20% (Rezania et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 65,
                    "end": 85,
                    "text": "(Rezania et al. 2007",
                    "ref_id": "BIBREF78"
                }
            ],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS)"
        },
        {
            "text": "j Therapie",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS)"
        },
        {
            "text": "Chemotherapie (Gemcitabin), Polychemotherapie (CHOP/Radiotherapie), Denileukin diftitox, Alemtuzumab (Rezania et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 101,
                    "end": 121,
                    "text": "(Rezania et al. 2007",
                    "ref_id": "BIBREF78"
                }
            ],
            "ref_spans": [],
            "section": "Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS)"
        },
        {
            "text": "Vermutlich entspricht dieses Lymphom der disseminierten Variante der pagetoiden Retikulose (Ketron-Goodman). ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutanes aggressives epidermotropes CD8 + -T-Zell-Lymphom (provisorisch)"
        },
        {
            "text": "j Epidemiologie",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Kutanes \u03b3/\u03b4-T-Zell-Lymphom (CGD-TCL; provisorisch)"
        },
        {
            "text": "Betroffen sind Kinder bis Erwachsene mittleren Alters. Mogamulizumab ist ein humanisierter monoklonaler Antik\u00f6rper gegen den CC-Chemokin-Rezeptor 4 (CCR4) auf Tumorzellen der Erwachsenen-T-Zell-Leuk\u00e4mie und T-Zell-Lymphomen. 50-75% bei CTCL, Ansprechdauer 10 Monate -10 Jahre (Zinzani et. al. 2010; Marchi et al. 2005; Jidar et al. 2009 ). ",
            "cite_spans": [
                {
                    "start": 276,
                    "end": 298,
                    "text": "(Zinzani et. al. 2010;",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 299,
                    "end": 318,
                    "text": "Marchi et al. 2005;",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 319,
                    "end": 336,
                    "text": "Jidar et al. 2009",
                    "ref_id": "BIBREF44"
                }
            ],
            "ref_spans": [],
            "section": "Kutanes \u03b3/\u03b4-T-Zell-Lymphom (CGD-TCL; provisorisch)"
        },
        {
            "text": "Kutane B-Zell-Lymphome (CBCL) machen etwa 25% der kutanen Lymphome aus und entwickeln sich aus einer Proliferation klonaler B-Lymphozyten, die in der Haut akkumulieren. Innerhalb der Gruppe der CBCL unterscheidet man zwischen niedrig-malignen Lymphomen, wie Keimzentrumslymphom (follikul\u00e4res Lymphom) und Marginalzonenlymphom, mit g\u00fcnstiger Prognose sowie Lymphomen mit aggressivem Verlauf und schlechter Prognose, wie den diffus gro\u00dfzelligen B-Zell-Lymphomen (diffus gro\u00dfzelliges B-Zell-Lymphom der unteren Extremit\u00e4t sowie das prim\u00e4r kutane intravaskul\u00e4re gro\u00dfzellige B-Zell-Lymphom; Grange et al. 2001; Burg et al. 2005) . Daneben haben prim\u00e4r kutane diffus gro\u00dfzellige Lymphomtypen, die weder dem diffus gro\u00dfzelligen B-Zell-Lymphom der unteren Extremit\u00e4t (Beintyp) noch prim\u00e4r kutanen follikul\u00e4ren Lymphomen zugeordnet werden k\u00f6nnen, in der Regel eine gute Prognose. Den Subgruppen der CBCL liegen verschiedene Zelltypen zugrunde, welche immunhistochemisch charakterisiert werden k\u00f6nnen (. Tab. 3.18) .",
            "cite_spans": [
                {
                    "start": 586,
                    "end": 605,
                    "text": "Grange et al. 2001;",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 606,
                    "end": 623,
                    "text": "Burg et al. 2005)",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 991,
                    "end": 1004,
                    "text": "(. Tab. 3.18)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Arten und Diagnostik Prim\u00e4r kutane B-Zell-Lymphome (CBCL)"
        },
        {
            "text": "Keimzentrumslymphom und Marginalzonenlymphom werden auch als kutane \u00c4quivalente der MALT-Lymphome (mucosa-associated lymphoid tissue) betrachtet und daher auch als SALT-Lymphome (skin-associated lymphoid tissue) bezeichnet. M\u00e4nner sind im Vergleich zu Frauen etwas h\u00e4ufiger betroffen (male-female-ratio 1.4) (Senff et al., 2008) .",
            "cite_spans": [
                {
                    "start": 308,
                    "end": 328,
                    "text": "(Senff et al., 2008)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Arten und Diagnostik Prim\u00e4r kutane B-Zell-Lymphome (CBCL)"
        },
        {
            "text": "= primary cutaneous follicle center lymphoma (PCFCL). knotige kutan-subkutane Infiltrate an der Haut, v. a. im Bereich des behaarten Kopfes, des Nackens oder des oberen Stammbereichs. Insbesondere am Stamm sind die Tumoren von erythemat\u00f6sen infiltrierten Plaques um geben (. Abb. 3.6), die der Entwicklung von Tumoren Monate bis Jahre vorausgehen k\u00f6nnen (fr\u00fcher: \"Retikulohistiozytom des R\u00fcckens\" oder \"Crosti-Lymphom\"). Extrakutane Mani festa tionen sind ungew\u00f6hnlich Positiv: CD20 + , CD79a + , bcl-6 + , negativ: CD5 -, CD10 -, Mum-1 -, bcl-2 -, FoxP1 + / -(Expression von FoxP1 gilt als prognostisch ung\u00fcnstiger Marker). Im Gegensatz zu nodalen follikul\u00e4ren B-Zell-Lymphomen exprimieren prim\u00e4r kutane follikul\u00e4re Lymphome in der Regel kein bcl-2 und die L\u00e4sionen sind meist solit\u00e4r. Positiv: CD20 + , CD79a + , Mum-1 + , bcl-2 + ; negativ: bcl-6 -, CD5 -, CD10 --, Cyclin D1. Bcl-2 und bcl-6 k\u00f6nnen in manchen F\u00e4llen f\u00fcr die Abgrenzung zum Keimzentrumslymphom hilfreich sein. Da insbesondere f\u00fcr das Marginalzonenlymphom ein Zusammenhang mit einer Borrelien-Infektion beschrieben wurde, wird nach EORTC/ISCL analog der Antibiotikabehandlung des MALT-Lymphoms die Gabe von Doxycyclin (2\u00d7100 mg/d p.o. \u00fcber 3 Wochen) oder Cephalosporinen als First-line-Therapie empfohlen, auch wenn ein Therapieansprechen bislang uneinheitlich bewertet wurde (Roggero et al. 2000; Senff et al. 2008 ).",
            "cite_spans": [
                {
                    "start": 1345,
                    "end": 1366,
                    "text": "(Roggero et al. 2000;",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 1367,
                    "end": 1384,
                    "text": "Senff et al. 2008",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Keimzentrumslymphom (follikul\u00e4res B-Zell-Lymphom)"
        },
        {
            "text": "Hierunter sind Lymphome mit einem diffusen Muster und einer monomorphen Proliferation von Zentroblasten und Immunoblasten klassifiziert. Aufgrund neuer Expressionsstudien wird zwischen zwei prognostisch unterschiedlichen Varianten unterschieden. Im Gegensatz zu den B-Zell-Lymphomen mit follikul\u00e4rem Aufbau zeigen diffus gro\u00dfzellige B-Zell-Lymphome h\u00e4ufig einen aggressiveren Verlauf mit lokalen Rezidiven nach Therapie und extrakutanem Befall und haben damit eine vergleichsweise schlechte Prognose (Grange et al. 2001) . Es liegen keine Ergebnisse gr\u00f6\u00dferer Therapiestudien f\u00fcr diese Lymphomentit\u00e4t vor.",
            "cite_spans": [
                {
                    "start": 500,
                    "end": 520,
                    "text": "(Grange et al. 2001)",
                    "ref_id": "BIBREF35"
                }
            ],
            "ref_spans": [],
            "section": "Diffuse gro\u00dfzellige B-Zell-Lymphome"
        },
        {
            "text": "Vor allem bei \u00e4lteren, zumeist weiblichen Patienten (>70 Jahre) zeigen sich multiple rasch aufschie\u00dfende erythemat\u00f6s-livide Plaques oder Tumorknoten, die zu gr\u00f6\u00dferen Herden konfluieren und im Verlauf ulzerieren. Das prim\u00e4r kutane diffus-gro\u00dfzellige Lymphom der unteren Extremit\u00e4t tritt h\u00e4ufiger, aber nicht ausschlie\u00dflich am Bein auf (. Abb. 3.8). H\u00e4ufig kommt es zur systemischen Ausbreitung mit einer schlechten Prognose. Positiv: CD20 + , CD79a + , bcl-6 + , Mum-1 + , bcl-2 + ; negativ: CD5 -, CD10 -, CD138 -. > Typisch f\u00fcr das prim\u00e4r kutane diffus-gro\u00dfzellige B-Zell-Lymphom der unteren Extremit\u00e4t ist eine starke Expression von bcl-2 und Mum-1.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutanes diffus-gro\u00dfzelliges B-Zell-Lymphom der unteren Extremit\u00e4t (Beintyp) j Klinik"
        },
        {
            "text": "Das prim\u00e4r kutane gro\u00dfzellige B-Zell-Lymphom vom Beintyp ist durch die Expression von bcl-2 und Mum-1 vom prim\u00e4r kutanen follikul\u00e4ren Lymphom abzugrenzen. Im Gegensatz zu diesem breitet es sich h\u00e4ufiger extrakutan aus. Der Verlust oder die Abnahme von p16 ist mit aggressiverem Verhalten und einer ung\u00fcnstigen klinischen Prognose assoziiert. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prim\u00e4r kutanes diffus-gro\u00dfzelliges B-Zell-Lymphom der unteren Extremit\u00e4t (Beintyp) j Klinik"
        },
        {
            "text": "Obinutuzumab (Gazyvaro \u00ae ) ist ein Typ-II Anti-CD20 Antik\u00f6rper, der f\u00fcr follikul\u00e4re Lymphome und CLL zugelassen ist. Er kann bei nicht vorbehandelten oder mit Rituximab vorbehandelten Lymphomen eingesetzt werden. Obinutuzumab wirkt direkt zytotoxisch mit Induktion eines nicht-apoptotischen, durch Lysosomen vermittelten Zelltod unabh\u00e4ngig von Komplement-und Immunsystem. Au\u00dferdem aktivieren die Anti-CD20 Antik\u00f6rper Makrophagen und nat\u00fcrliche Killerzellen (NK-Zellen) durch Bindung an den FC\u03b3IIIa-Rezeptor, der auf diesen Effektorzellen exprimiert wird.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Obinutuzumab (Gazyvaro \u00ae )"
        },
        {
            "text": "Anti-CD20; Mabthera \u00ae , Rituxan \u00ae , Truxima \u00ae j Onkologische Indikationen 5 Zugelassen: CBCL; PCFCL/PCMZL (rezidivierend, therapierefrakt\u00e4r), CD20 + -gro\u00dfzellige diffuse BCL, CLL, NHL: follikul\u00e4re Lymphome, CD20 + -B-Zell-Neoplasien Chim\u00e4rer monoklonaler Antik\u00f6rper bindet an das transmembran\u00f6se B-Lymphozytenantigen CD20 (auf gesunden B-Zellen und 95% der NHL) und f\u00fchrt zur Apoptose und Lyse der B-Zelle durch entsprechende Signalkaskaden sowie \u00fcber antik\u00f6rper-und komplementabh\u00e4ngige zellul\u00e4re Zytotoxizit\u00e4t. Trotz Depletion der peripheren B-Lymphozyten kommt es nur zu einer moderaten Infektanf\u00e4lligkeit. Erholung der B-Zell-Zahl ca. 9-12 Monate nach Therapieende. Anti-CD20 ist der erste Antik\u00f6rper, der zur Behandlung von Krebs zugelassen wurde. Er stellt heute eine Standardtherapie in der Behandlung niedrig-maligner und follikul\u00e4rer NHL dar, bei aggressiven BCL meist in Kombination mit einer konventionellen Chemotherapie (R-CHOP; van Oers et al. 2006; Habermann 2006; Gellrich et al. 2005; Kerl et al. 2006 ). j Ansprechrate 90% (CR 60-70%) bei systemischer Anwendung (Gellrich et al. 2005) , intral\u00e4sionale Anwendung bislang Einzelfallberichte und kleine Serien Paul et al. 2001; Kerl et al. 2006) . Mediane Remissionsdauer 4-30 Monate nach systemischer (Gellrich et al. 2005) und 6 Monate nach intral\u00e4sionaler Anwendung (Kerl et al. 2006 Aggressives blast\u00e4res Lymphom mit h\u00e4ufig prim\u00e4rer kutaner Beteiligung und Expression von CD123 (Interleukin-3\u03b1-Rezeptor), einem Marker dendritischer Vorl\u00e4uferzellen, was auf eine onkogene Transformation plasmozytoider Monozyten (= plasmozytoide Typ-2-dendritische Zellen/DC2) schlie\u00dfen l\u00e4sst (Petrella et al. 1999; Willemze et al. 2005) . In der ehemaligen WHO-Klassifikation wurde es aufgrund der CD56 + -/NCAM-Expression (NCAM = NK-cell-associated neural cell adhesion molecule) und des blastenf\u00f6rmigen Erscheinungsbilds noch als NK-Zell-Lymphom eingeordnet (Dummer et al. 1996b; Savoia et al. 1997; Natkunam et al. 1999 ).",
            "cite_spans": [
                {
                    "start": 941,
                    "end": 962,
                    "text": "van Oers et al. 2006;",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 963,
                    "end": 978,
                    "text": "Habermann 2006;",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 979,
                    "end": 1000,
                    "text": "Gellrich et al. 2005;",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 1001,
                    "end": 1017,
                    "text": "Kerl et al. 2006",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1079,
                    "end": 1101,
                    "text": "(Gellrich et al. 2005)",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 1174,
                    "end": 1191,
                    "text": "Paul et al. 2001;",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 1192,
                    "end": 1209,
                    "text": "Kerl et al. 2006)",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1266,
                    "end": 1288,
                    "text": "(Gellrich et al. 2005)",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 1333,
                    "end": 1350,
                    "text": "(Kerl et al. 2006",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1643,
                    "end": 1665,
                    "text": "(Petrella et al. 1999;",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 1666,
                    "end": 1687,
                    "text": "Willemze et al. 2005)",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 1911,
                    "end": 1932,
                    "text": "(Dummer et al. 1996b;",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 1933,
                    "end": 1952,
                    "text": "Savoia et al. 1997;",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 1953,
                    "end": 1973,
                    "text": "Natkunam et al. 1999",
                    "ref_id": "BIBREF63"
                }
            ],
            "ref_spans": [],
            "section": "Rituximab"
        },
        {
            "text": "j Klinik",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Rituximab"
        },
        {
            "text": "Zun\u00e4chst meist einzelne, dann multiple r\u00f6tlichbr\u00e4unliche bis blau-livide kontusiforme Plaques oder Knoten, bevorzugt bei M\u00e4nnern mittleren und h\u00f6heren Lebensalters (. Abb. 3.9). In ca. 50% der F\u00e4lle Erstmanifestation an der Haut, so dass zum Zeitpunkt der Diagnose eine Beteiligung des peripheren Blutes oder Knochenmarks noch nicht nachweisbar ist (aleuk\u00e4mische Leukaemia cutis).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Rituximab"
        },
        {
            "text": "j Prognose",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Rituximab"
        },
        {
            "text": "Sehr aggressiver Verlauf mit nach einigen Monaten klinisch relevanter Mitbeteiligung des Knochenmarks. Die Prognose ist sehr schlecht. Nach initial gutem Ansprechen auf eine Chemotherapie kommt es in der Regel schnell zum . Abb. 3.9 CD4 + -/CD56 + -h\u00e4matodermische Neoplasien: plasmozytoides dendritisches Lymphom/dendritische Zell-Leuk\u00e4mie (vormals blast\u00e4res NK-Zell-Lymphom)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Rituximab"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Bexarotene therapy for mycosis fungoides and S\u00e9zary syndrome",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Abbott",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Morris",
                    "suffix": ""
                },
                {
                    "first": "Russell-Jones",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Hung",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bashir",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Scarisbrick",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Br J Dermatol",
            "volume": "160",
            "issn": "",
            "pages": "1299--1307",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Unilesional (segmental) mycosis fungoides presenting in childhood",
            "authors": [
                {
                    "first": "Q",
                    "middle": [
                        "A"
                    ],
                    "last": "Alsaleh",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nanda",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Baker",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Al-Sabah",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Calonje",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Pediatr Dermatol",
            "volume": "21",
            "issn": "",
            "pages": "558--560",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Assaf",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gellrich",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Steinhoff",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Nashan",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Weisse",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Dippel",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Coors",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Stein",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gollin",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Henke",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Adam-Murati",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Koch",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Klemke",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Dtsch Dermatol Ges",
            "volume": "5",
            "issn": "",
            "pages": "662--668",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Assaf",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gellrich",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Clin Pathol",
            "volume": "60",
            "issn": "",
            "pages": "981--989",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the longterm follow-up data of 219 patients and guidelines for diagnosis and treatment",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Bekkenk",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Geelen",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Van Voorst",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "Vader",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Heule",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Geerts",
                    "suffix": ""
                },
                {
                    "first": "W A",
                    "middle": [],
                    "last": "Van Vloten",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Meijer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Blood",
            "volume": "95",
            "issn": "",
            "pages": "3653--3661",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Peripheral T-cell-lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Bekkenk",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Vermeer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Jansen",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Blood",
            "volume": "102",
            "issn": "",
            "pages": "2213--2219",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "CD56+ haematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Bekkenk",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Jansen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Meijer",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Ann Oncol",
            "volume": "15",
            "issn": "",
            "pages": "1097--110",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Induction of human tumor-loaded dendritic cells",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Berger",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Hanlon",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schechner",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Glusac",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Christensen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Snyder",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Holloway",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tigelaar",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Edelson",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Int J Cancer",
            "volume": "91",
            "issn": "",
            "pages": "438--447",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Primary cutaneous CD8-positive epidermotropic cytotoxic T-cell-lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior",
            "authors": [
                {
                    "first": "Mg1",
                    "middle": [],
                    "last": "Bernengo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Quaglino",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Comessatti",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ortoncelli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Novelli",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lisa",
                    "suffix": ""
                },
                {
                    "first": "Mt ; E",
                    "middle": [],
                    "last": "Fierro",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Tomasini",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Vermeer",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Haematologica",
            "volume": "92",
            "issn": "",
            "pages": "483--492",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Bunn",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "I"
                    ],
                    "last": "Lamberg",
                    "suffix": ""
                }
            ],
            "year": 1979,
            "venue": "Cancer Treat Rep",
            "volume": "63",
            "issn": "",
            "pages": "725--728",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Kempf",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cozzio",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Feit",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Jaffe",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "Berti",
                    "middle": [
                        "E"
                    ],
                    "last": "Cerroni",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Chimenti",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Diaz-Perez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Grange",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Harris",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "L"
                    ],
                    "last": "Kazakov",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "V"
                    ],
                    "last": "Kerl",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kurrer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Meijer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Pimpinelli",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ralfkiaer",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Russell-Jones",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sander",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Santucci",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Swerdlow",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Vermeer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Wechsler",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Cutan Pathol",
            "volume": "32",
            "issn": "",
            "pages": "647--674",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cerroni",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zochling",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Putz",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kerl",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Cutan Pathol",
            "volume": "24",
            "issn": "",
            "pages": "457--461",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Narrowband TL-01 phototherapy for patch-stage mycosis fungoides",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Dawe",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "T"
                    ],
                    "last": "Evans",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lowe",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ferguson",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Arch Dermatol",
            "volume": "136",
            "issn": "",
            "pages": "748--752",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Coors",
                    "suffix": ""
                },
                {
                    "first": "Von",
                    "middle": [],
                    "last": "Den Driesch",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Br J Dermatol",
            "volume": "143",
            "issn": "",
            "pages": "127--131",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "D&apos;amore",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Radford",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Relander",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Jerkeman",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tilly",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Osterborg",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Morschhauser",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gramatzki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dreyling",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hagberg",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "De Masson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Guitera",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Brice",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Moulonguet",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Mouly",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Bouaziz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Battistella",
                    "suffix": ""
                },
                {
                    "first": "Madelaine",
                    "middle": [
                        "I"
                    ],
                    "last": "Roux",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ram-Wolff",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cayuela",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Bachelez",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bensussan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Michel",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Br J Dermatol",
            "volume": "170",
            "issn": "",
            "pages": "720--724",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "A rational approach to the therapy of cutaneous T-cell lymphomas",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "H\u00e4ffner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hess",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Onkologie",
            "volume": "19",
            "issn": "",
            "pages": "226--230",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "A primary cutaneous non-T non-B CD4+, CD56+ lymphoma",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Potoczna",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "H\u00e4ffner",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gilardi",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zimmermann",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Arch Derm",
            "volume": "132",
            "issn": "",
            "pages": "550--553",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Assaf",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gniadecki",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hauschild",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ranki",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Eur J Cancer",
            "volume": "43",
            "issn": "",
            "pages": "2321--2329",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Beyer",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hymes",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Epping",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bernards",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Steinhoff",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kerl",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Heath",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Ahern",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Hardwick",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Garcia-Vargas",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Baumann",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rizvi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Frankel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Assaf",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Leuk Lymphoma",
            "volume": "53",
            "issn": "",
            "pages": "1501--1508",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012",
            "authors": [
                {
                    "first": "R1",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Quaglino",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Becker",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hasan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Karrasch",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Weichenthal",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cozzio",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Bernengo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Clin Oncol",
            "volume": "30",
            "issn": "",
            "pages": "4091--4097",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and S\u00e9zary syndrome)",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Scarisbrick",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Olsen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rozati",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Eggmann",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Goldinger",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hutchinson",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Geskin",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Illidge",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Giuliano",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Elder",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Ann Oncol",
            "volume": "25",
            "issn": "",
            "pages": "1807--1812",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "G"
                    ],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Olsen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Crowley",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Yocum",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Arch Dermatol",
            "volume": "137",
            "issn": "",
            "pages": "581--593",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hymes",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Heald",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Breneman",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "G"
                    ],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Myskowski",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Crowley",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Yocum",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Clin Oncol",
            "volume": "19",
            "issn": "",
            "pages": "2456--2471",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "C"
                    ],
                    "last": "Pinter-Brown",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "M"
                    ],
                    "last": "Foss",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Sokol",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Jorgensen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Challagundla",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Dwyer",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Kurman",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ballerini",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Blood",
            "volume": "125",
            "issn": "",
            "pages": "1883--1889",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Bexarotene: a clinical review",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "T"
                    ],
                    "last": "Farol",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "B"
                    ],
                    "last": "Hymes",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Expert Rev Anticancer Ther",
            "volume": "4",
            "issn": "",
            "pages": "180--188",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Felcht",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Booken",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Stroebel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Goerdt",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Klemke",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Am Acad Dermatol",
            "volume": "64",
            "issn": "",
            "pages": "135--143",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Fierro",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Quaglino",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Savoia",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Verrone",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Bernengo",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Leuk Lymphoma",
            "volume": "31",
            "issn": "",
            "pages": "583--588",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Foss",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Leuk Lymph",
            "volume": "44",
            "issn": "3",
            "pages": "55--61",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "A phase-1 trial of bexarotene ans denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Foss",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Demierre",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Divenuti",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Blood",
            "volume": "106",
            "issn": "",
            "pages": "454--457",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Foss",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lerner",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Waksman",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Clin Lymphoma Myeloma Leuk",
            "volume": "16",
            "issn": "",
            "pages": "637--643",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gellrich",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Muche",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wilks",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "C"
                    ],
                    "last": "Jasch",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Voit",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Fischer",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Audring",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Br J Dermatol",
            "volume": "153",
            "issn": "",
            "pages": "167--173",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-lie T-cell-lymphoma: a systematic Literatur analysis of 156 patients reported in the literature",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Go",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Wester",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Cancer",
            "volume": "101",
            "issn": "",
            "pages": "1404--1413",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Goodlad",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Davidson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hollowood",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Batstone",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Ho-Yen",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Do",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Histopathology",
            "volume": "37",
            "issn": "",
            "pages": "501--508",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Grange",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Bekkenk",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wechsler",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Meijer",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cerroni",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bernengo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bosq",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hedelin",
                    "suffix": ""
                },
                {
                    "first": "Fink",
                    "middle": [],
                    "last": "Puches",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Van Vloten",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "A"
                    ],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Joly",
                    "middle": [
                        "P"
                    ],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Clin Oncol",
            "volume": "19",
            "issn": "",
            "pages": "3602--3610",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Habermann",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Weller",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "A"
                    ],
                    "last": "Morrison",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Gascoyne",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Cassileth",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Cohn",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Dakhil",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Woda",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "I"
                    ],
                    "last": "Fisher",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "A"
                    ],
                    "last": "Peterson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Horning",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Clin Oncol",
            "volume": "24",
            "issn": "",
            "pages": "3121--3127",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Heald",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rook",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Perez",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Wintroub",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Jegasothy",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gasparro",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Berger",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Edelson",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Am Acad Dermatol",
            "volume": "27",
            "issn": "",
            "pages": "427--433",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Intralesional therapy with anti-CD20-antibody in primary cutaneous B-cell Lymphoma",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Heinzerling",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Kempf",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hess-Schmid",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Arch Derm",
            "volume": "136",
            "issn": "",
            "pages": "374--378",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Reduction of tumor burden and stablization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomas",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Heinzerling",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Urbanek",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "O"
                    ],
                    "last": "Funk",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Peker",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Bleck",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Neuber",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Vondendriesch",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Cancer",
            "volume": "89",
            "issn": "",
            "pages": "1835--1844",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Photochemotherapy for cutaneous T cell lymphoma. A follow-up study",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "H\u00f6nigsmann",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Brenner",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Rauschmeier",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Konrad",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wolff",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "J Am Acad Dermatol",
            "volume": "10",
            "issn": "",
            "pages": "238--245",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Systematic review of combination therapies for mycosis fungoides",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Humme",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nast",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Erdmann",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Vandersee",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Beyer",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Cancer Treat Rev",
            "volume": "40",
            "issn": "",
            "pages": "927--933",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Illidge",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Counsell",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Scarisbrick",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Gilson",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Popova",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Patrick",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cowan",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Br J Cancer",
            "volume": "109",
            "issn": "",
            "pages": "2566--2573",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "The 2008 WHO classification of lymphomas: implications for clinical practice and translational research",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Jaffe",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Hematology Am Soc Hematol Educ Program",
            "volume": "",
            "issn": "",
            "pages": "523--531",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Jidar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ingen-Housz-Oro",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Beylot-Barry",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Paul",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chaoui",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sigal-Grinberg",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Morel",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dubertret",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bachelez",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Br J Dermatol",
            "volume": "161",
            "issn": "",
            "pages": "660--663",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome)",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "W"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Rosenthal",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "D"
                    ],
                    "last": "Wilson",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Cancer",
            "volume": "85",
            "issn": "",
            "pages": "1985--1995",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Kavanaugh",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kolesar",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am J Health Syst Pharm",
            "volume": "67",
            "issn": "",
            "pages": "793--797",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kerl",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Prins",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Saurat",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "French",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Br J Dermatol",
            "volume": "155",
            "issn": "",
            "pages": "1197--1200",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Kessler",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Levine",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Lynch",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Booth",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "L"
                    ],
                    "last": "Meyskens",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Arch Dermatol",
            "volume": "123",
            "issn": "",
            "pages": "201--204",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Obitz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gniadecki",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Iversen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Osterborg",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Illidge",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Schwarz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kaufmann",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Knudsen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lisby",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Baadsgaard",
                    "suffix": ""
                },
                {
                    "first": "Knox",
                    "middle": [],
                    "last": "Sjv",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Blood",
            "volume": "109",
            "issn": "",
            "pages": "4655--4662",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pinter-Brown",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Rook",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Porcu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Horwitz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tokura",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "MAVORIC Investigators",
            "volume": "19",
            "issn": "",
            "pages": "1192--1204",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Girardi",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Ann N Y Acad Sci",
            "volume": "941",
            "issn": "",
            "pages": "123--138",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Malignant lymphoma. 2. Therapy",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Knospe",
                    "suffix": ""
                }
            ],
            "year": 1974,
            "venue": "Postgrad Med",
            "volume": "55",
            "issn": "",
            "pages": "211--218",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Changing incidence trends of cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Korgavkar",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xiong",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Weinstock",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "JAMA Dermatol",
            "volume": "149",
            "issn": "",
            "pages": "1295--1299",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kutting",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bonsmann",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Metze",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Luger",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cerroni",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Am Acad Dermatol",
            "volume": "36",
            "issn": "",
            "pages": "311--314",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Kuzel",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "H"
                    ],
                    "last": "Roenigk",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Samuelson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Herrmann",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hurria",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "W"
                    ],
                    "last": "Rademaker",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Rosen",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Clin Oncol",
            "volume": "13",
            "issn": "",
            "pages": "257--263",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Current and emerging treatment strategies for cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lansigan",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "M"
                    ],
                    "last": "Foss",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Drugs",
            "volume": "70",
            "issn": "",
            "pages": "273--786",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lundin",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hagberg",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Repp",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Cavallin-St\u00e5hl",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fred\u00e9n",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Juliusson",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rosenblad",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Tj\u00f8nnfjord",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wiklund",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Osterborg",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Blood",
            "volume": "101",
            "issn": "",
            "pages": "4267--4272",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "S"
                    ],
                    "last": "Mann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sridhara",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Abraham",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "P"
                    ],
                    "last": "Booth",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Verbois",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Morse",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Jee",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pope",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Harapanhalli",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dagher",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Farrell",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Justice",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Pazdur",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Clin Cancer Res",
            "volume": "13",
            "issn": "",
            "pages": "2318--2322",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Gemcitabine as frontline treatment for cutaneous T-cell lym phoma: phase II study of 32 patients",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Marchi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Alinari",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tani",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Stefoni",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pimpinelli",
                    "suffix": ""
                },
                {
                    "first": "Berti",
                    "middle": [
                        "E"
                    ],
                    "last": "Pagano",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bernengo Mg",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zaja",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rupoli",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pileri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baccarani",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Zinzani",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Cancer",
            "volume": "104",
            "issn": "",
            "pages": "2437--2441",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre study",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Maza",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gellrich",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Assaf",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Beyer",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Spilker",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Orawa",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Munz",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Steinhoff",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Leuk Lymphoma",
            "volume": "49",
            "issn": "",
            "pages": "1702--1709",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and S\u00e9zary syndrome",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "Y"
                    ],
                    "last": "Mcgirt",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Thoburn",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hess",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Vonderheid",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Photodermatol Photoimmunol Photomed",
            "volume": "26",
            "issn": "",
            "pages": "182--191",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Muniesa",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Estrach",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Pujol",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gallardo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Garcia-Muret",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Climent",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Servitje",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Am Acad Dermatol",
            "volume": "62",
            "issn": "3",
            "pages": "418--444",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Natkunam",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "R"
                    ],
                    "last": "Smoller",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Zehnder",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "F"
                    ],
                    "last": "Dorfman",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Warnke",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Am J Surg Pathol",
            "volume": "23",
            "issn": "",
            "pages": "571--581",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Agranular CD4+/ CD56+ Hematodermic Neoplasm. A distinct entity described in the recent World Health Organization-European Organization for Research and Treatment of Cancer Classification for Cutaneous Lymphomas",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Niakosari",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sur",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Arch Pathol Lab Med",
            "volume": "131",
            "issn": "",
            "pages": "149--151",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Olsen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Frankel",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vonderheid",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Jegasothy",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Heald",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Oseroff",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pinter-Brown",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bowen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kuzel",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Fivenson",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Foss",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Glode",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Molina",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stewart",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stevens",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Craig",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Reuben",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bacha",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nichols",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Clin Oncol",
            "volume": "19",
            "issn": "",
            "pages": "376--388",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Olsen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vonderheid",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pimpinelli",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zackheim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Estrach",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lamberg",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ranki",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Heald",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pittelkow",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Bernengo Mg",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Laroche",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Trautinger",
                    "suffix": ""
                },
                {
                    "first": "S; Iscl/",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Eortc",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Blood",
            "volume": "110",
            "issn": "",
            "pages": "1713--1722",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "S\u00e9zary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Olsen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Rook",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zic",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Porcu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Querfeld",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Demierre",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pittelkow",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "D"
                    ],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pinter-Brown",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Advani",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Parker",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Junkins-Hopkins",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Foss",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Cacchio",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Intralesional rituximab for cutaneous B-cell lymphoma",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Paul",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Radny",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Krober",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Paul",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Blaheta",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Garbe",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Br J Dermatol",
            "volume": "144",
            "issn": "",
            "pages": "1239--1243",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC)",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Petrella",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Dalac",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Maynadi\u00e9",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Mugneret",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Thomine",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Courville",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Joly",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lenormand",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Arnould",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wechsler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rieux",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bosq",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Avril",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bernheim",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Molina",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Devidas",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Delfau-Larue",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gaulard",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lambert",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Am J Surg Pathol",
            "volume": "23",
            "issn": "",
            "pages": "137--146",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell-lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Petrella",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Comeau",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Maynadie",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Am J Surg Pathol",
            "volume": "26",
            "issn": "",
            "pages": "852--862",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Piccinno",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Caccialanza",
                    "suffix": ""
                },
                {
                    "first": "Berti",
                    "middle": [
                        "E"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Eur J Dermatol",
            "volume": "13",
            "issn": "",
            "pages": "49--52",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ponzoni",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Ferreri",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Campo",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Facchetti",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mazzucchelli",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yoshino",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Murase",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Pileri",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Doglioni",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Zucca",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Cavalli",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nakamura",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Clin Oncol",
            "volume": "25",
            "issn": "",
            "pages": "3168--3173",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Prince",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Horwitz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Scarisbrick",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Quaglino",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Zinzani",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wolter",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Sanches",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Ortiz-Romero",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "E"
                    ],
                    "last": "Akilov",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Geskin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Trotman",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Dalle",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Weichenthal",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Walewski",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Fisher",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Dr\u00e9no",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Feldman",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Kuzel",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Palanca-Wessels",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Zagadailov",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "L"
                    ],
                    "last": "Trepicchio",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Huebner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Little",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Lancet",
            "volume": "17",
            "issn": "",
            "pages": "31266--31267",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with ad-Literatur vanced or refractory mycosis fungoides or S\u00e9zary syndrome",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Quereux",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Marques",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Nguyen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bedane",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "&apos;incan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dereure",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Puzenat",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Claudy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Joly",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Delaunay",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Beylot-Barry",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Vabres",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Celerier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sasolas",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Grange",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Khammari",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dreno",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arch Dermatol",
            "volume": "144",
            "issn": "6",
            "pages": "727--733",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Querfeld",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Mehta",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Rosen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guitart",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rademaker",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gerami",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Kuzel",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Leuk Lymphoma",
            "volume": "50",
            "issn": "",
            "pages": "1969--1976",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Ramsay",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Lish",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "B"
                    ],
                    "last": "Yalowitz",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Soter",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Arch Der matol",
            "volume": "128",
            "issn": "",
            "pages": "931--933",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Classification and treatment of rare and aggressive types of peripheral T-cell( natural killer-cell lymphomas of the skin",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Rezania",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Sokol",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "D"
                    ],
                    "last": "Cualig",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Cancer Control",
            "volume": "14",
            "issn": "",
            "pages": "112--123",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "H"
                    ],
                    "last": "Roenigk",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Kuzel",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Skoutelis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Springer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Caro",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Gilyon",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Variakojis",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kaul",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Bunn",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Jr",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "J Invest Dermatol",
            "volume": "95",
            "issn": "",
            "pages": "198--205",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Roggero",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Zucca",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mainetti",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bertoni",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Valsangiacomo",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Pedrinis",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Borisch",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Piffaretti",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Cavalli",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "G"
                    ],
                    "last": "Isaacson",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Hum Pathol",
            "volume": "31",
            "issn": "",
            "pages": "263--268",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Photopheresis: clinical applications and mechanism of action",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Rook",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Suchin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Kao",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "K"
                    ],
                    "last": "Yoo",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Macey",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Denardo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "G"
                    ],
                    "last": "Bromely",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Geng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Junkins-Hopkins",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Lessin",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Investig Dermatol Symp Proc",
            "volume": "4",
            "issn": "",
            "pages": "85--90",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "A denileukin diftitox (Ontak) associated retinopathy?",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Ruddle",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Harper",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "H\u00f6nemann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Seymour",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Prince",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Br J Ophthalmol",
            "volume": "90",
            "issn": "",
            "pages": "1070--1071",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies",
            "authors": [
                {
                    "first": "Russell",
                    "middle": [],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Br J Dermatol",
            "volume": "142",
            "issn": "",
            "pages": "16--21",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Savoia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Fierro",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Novelli",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Quaglino",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Verrone",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Geuna",
                    "suffix": ""
                },
                {
                    "first": "Bernengo",
                    "middle": [],
                    "last": "Mg",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Scarisbrick",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Azurdia",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Illidge",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Parry",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Graham-Brown",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cowan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gallop-Evans",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wachsmuth",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Eagle",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Wierzbicki",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Soran",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Wain",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Br J Dermatol",
            "volume": "168",
            "issn": "1",
            "pages": "192--200",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas",
            "authors": [
                {
                    "first": "H-J",
                    "middle": [],
                    "last": "Schmoll",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "H\u00f6ffgen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Possinger",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Kompendium Internistische Onkologie",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Springer ; Noordijk",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "Berti",
                    "middle": [
                        "E"
                    ],
                    "last": "Cerroni",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hoppe",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "T"
                    ],
                    "last": "Pimpinelli",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Rosen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Vermeer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Blood",
            "volume": "112",
            "issn": "",
            "pages": "1600--1609",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Presentation and management of intravascular large B-cell lymphoma",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Shimada",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kinoshita",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Naoe",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nakamura",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Lancet Oncol",
            "volume": "10",
            "issn": "",
            "pages": "895--902",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "N"
                    ],
                    "last": "Slater",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Br J Dermatol",
            "volume": "153",
            "issn": "",
            "pages": "874--880",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "G"
                    ],
                    "last": "Otte",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Luger",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Henz",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kuhl",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Zwingers",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Blood",
            "volume": "92",
            "issn": "",
            "pages": "3578--3581",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "SK2 -Kurzleitlinie -Kutane Lymphone (ICS10 C82-C86) Update",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Assaf",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Klempke",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Nashan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Weichenthal",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sterry",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Effectiveness of photopheresis in Sezary syndrome",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Stevens",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Bowen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "King",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "W"
                    ],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Margolis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Parry",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Rook",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "P"
                    ],
                    "last": "Stricklin",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Suchin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "D"
                    ],
                    "last": "Tharp",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vonderheid",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Zic",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Arch Dermatol",
            "volume": "135",
            "issn": "",
            "pages": "995--997",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Results of a phase II trial of oral bexarotene (Targretin) combined ' with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "Dj1",
                    "middle": [],
                    "last": "Straus",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kuzel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Horwitz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Demierre",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Myskowski",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Steckel",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Cancer",
            "volume": "109",
            "issn": "",
            "pages": "1799--1803",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "The 2016 revision of the World Health Organization classification of lymphoid neoplasms",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Swerdlow",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Campo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Pileri",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "L"
                    ],
                    "last": "Harris",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Stein",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Siebert",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Advani",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ghielmini",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Salles",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Zelenetz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Jaffe",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Blood",
            "volume": "127",
            "issn": "",
            "pages": "2375--2390",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "EORTC consensus recommendations for the treatment of mycosis fungoides/S\u00e9zary syndrome",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "A"
                    ],
                    "last": "Teicher",
                    "suffix": ""
                },
                {
                    "first": "R ; F",
                    "middle": [],
                    "last": "Hassan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Peris",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Laroche",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "&apos;incan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ranki",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pimpinelli",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ortiz-Romero",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Estrach",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Lancet Oncol",
            "volume": "17",
            "issn": "",
            "pages": "1014--1030",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/S\u00e9zary syndrome -Update",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Trautinger",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Eder",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Assaf",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bagot",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cozzio",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gniadecki",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Klemke",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Ortiz-Romero",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Papadavid",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pimpinelli",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Quaglino",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ranki",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Scarisbrick",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "V\u00e4kev\u00e4",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Vermeer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Eur J Cancer",
            "volume": "77",
            "issn": "",
            "pages": "57--74",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Vonderheid",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Bernengo Mg",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Duvic",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Heald",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Laroche",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Olsen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pittelkow",
                    "suffix": ""
                },
                {
                    "first": "Russell-Jones",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Takigawa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "R;",
                    "middle": [],
                    "last": "Iscl",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Am Acad Dermatol",
            "volume": "46",
            "issn": "",
            "pages": "95--106",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Van Oers",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Klasa",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "E"
                    ],
                    "last": "Marcus",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wolf",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kimby",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Gascoyne",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jack",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van&apos;t Veer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vranovsky",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Holte",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Glabbeke",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Teodorovic",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rozewicz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hagenbeek",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Blood",
            "volume": "108",
            "issn": "",
            "pages": "3295--3301",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Localized cutaneous small to medium-sized pleomorphic T-cell-lymphoma: a report of 3 cases stable for years",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Von Den Driesch",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Coors",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Am Acad Dermatol",
            "volume": "46",
            "issn": "",
            "pages": "531--535",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "Epidemiology of mycosis fungoides",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Weinstock",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Semin Dermatol",
            "volume": "13",
            "issn": "",
            "pages": "154--159",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056)",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Whittaker",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ortiz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ranki",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hasan",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Meulemans",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gellrich",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Knobler",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Stadler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Karrasch",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Br J Dermatol",
            "volume": "167",
            "issn": "",
            "pages": "678--687",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "WHO-EORTC classification for cutaneous lymphomas",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Jaffe",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Burg",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cerroni",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Berti",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Swerdlow",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Blood",
            "volume": "105",
            "issn": "",
            "pages": "3768--3785",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Subcutaneous panniculitis-like T-cell-lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Willemze",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Jansen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cerroni",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Blood",
            "volume": "111",
            "issn": "",
            "pages": "838--845",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Wiseman",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "I"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "Multani",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "Witzig",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Spies",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "L"
                    ],
                    "last": "Bartlett",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Schilder",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Murray",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Saleh",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Allen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Grillo-L\u00f3pez",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "White",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Blood",
            "volume": "99",
            "issn": "",
            "pages": "4336--4342",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "Pegylated doxorubicin for primary cutaneous T cell lymphoma: a report on ten patients with follow-up",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Wollina",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Graefe",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kaatz",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Ann N Y Acad Sci",
            "volume": "941",
            "issn": "",
            "pages": "214--216",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Wollina",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dummer",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Brockmeyer",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Cancer",
            "volume": "98",
            "issn": "",
            "pages": "99--1001",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE)",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Tung",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Haeffner",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "F"
                    ],
                    "last": "Crooks",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Liao",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Orozco",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Veelken",
                    "suffix": ""
                },
                {
                    "first": "M E",
                    "middle": [],
                    "last": "Kadin",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Koh",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Heald",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Barnhill",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sklar",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "J Invest Dermatol",
            "volume": "103",
            "issn": "",
            "pages": "34--41",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yamaguchi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Kwong",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "S"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Maeda",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hashimoto",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Suh",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Izutsu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ishida",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Isobe",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Sueoka",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Suzumiya",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kodama",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kimura",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Hyo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nakamura",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Oshimi",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Suzuki",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "So",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Clin Oncol",
            "volume": "29",
            "issn": "33",
            "pages": "4410--4416",
            "other_ids": {}
        },
        "BIBREF110": {
            "ref_id": "b110",
            "title": "Low-dose methotrexate for the Sezary syndrome",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Zackheim",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "H"
                    ],
                    "last": "Epstein",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "J Am Acad Dermatol",
            "volume": "21",
            "issn": "",
            "pages": "757--762",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "Lowdose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Zackheim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kashani-Sabet",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Hwang",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Am Acad Dermatol",
            "volume": "34",
            "issn": "",
            "pages": "626--631",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "Topical corticosteroids for mycosis fungoides. Experience in 79 patients",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Zackheim",
                    "suffix": ""
                },
                {
                    "first": "Kashani",
                    "middle": [],
                    "last": "Sabet",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Amin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Arch Dermatol",
            "volume": "134",
            "issn": "",
            "pages": "949--954",
            "other_ids": {}
        },
        "BIBREF113": {
            "ref_id": "b113",
            "title": "Die Therapie der primaren kutanen B-Zell-Lymphome",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zenahlik",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fink Puches",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Kapp",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kerl",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cerroni",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Hautarzt",
            "volume": "51",
            "issn": "",
            "pages": "19--24",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Zinzani",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Musuraca",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tani",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Stefoni",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Marchi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fina",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pellegrini",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Alinari",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Derenzini",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "De Vivo",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Sabattini",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pileri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baccarani",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Clin Oncol",
            "volume": "25",
            "issn": "",
            "pages": "4293--4297",
            "other_ids": {}
        },
        "BIBREF115": {
            "ref_id": "b115",
            "title": "Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Zinzani",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Venturini",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Stefoni",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fina",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pellegrini",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Derenzini",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gandolfi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Broccoli",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Argnani",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Quirini",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pileri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baccarani",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Ann Oncol",
            "volume": "21",
            "issn": "",
            "pages": "860--863",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Zinzani",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Karlin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Radford",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Caballero",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Fields",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Chamuleau",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Amore",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Haioun",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Thieblemont",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gonz\u00e1lez-Barca",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Garc\u00eda",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "W"
                    ],
                    "last": "Van Imhoff",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dwyer",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Morschhauser",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Haematologica",
            "volume": "101",
            "issn": "",
            "pages": "407--410",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Lymphome (Willemze 2005, Swerd low et al. 2016, Trautinger et al. 2017) 5 Kutane T-Zell-Lymphome (CTCL) Prim\u00e4r kutanes akrales CD8+ T-Zell-Lymphom (provisorisch) -Prim\u00e4r kutane periphere T-Zell-Lymphome, nicht genauer spezifiziert (NOS) Tab. 3.1 Kutane T-Zell-Lymphome (WHO 2005) -Prognose und zugrunde liegender Zelltyp 5 Kutane B-Zell-Lymphome (CBCL)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "KlinikSolit\u00e4re oder gruppiert stehende, blau-rote bis rot-braune, typischerweise gr\u00f6\u00dfere (>3 cm), Abb. 3.6 Keimzentrumslymphom (follikul\u00e4res B-Zell-Lymphom, PCFCL)",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Alemtuzumab (Mab Campath \u00ae ) Anti-CD52-AK -170 3.2.17 Zanolimumab (Humax \u00ae ): Anti-CD4-AK -171 3.2.18 Bortezomib (Velcade \u00ae ): Proteasom-Inhibitor -171 3.2.19 Forodesin (Immucillin \u00ae ): Purin-Nukleotid-Phosphorylase-",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "CD8 -, CD30 -) auf. In seltenen F\u00e4llen k\u00f6nnen sie auch CD4und CD8 + sein.. Tab. 3.2 TNMB-Klassifikation der ISCL/EORTC(Olsen et al. 2007) Signifikanz, unabh\u00e4ngig von der weiteren Klassifizierung. Theoretisch kann also ein Patient in ausgepr\u00e4gtem Ekzemstadium ohne Lymphknoten-oder weiteren Metastasen durch entsprechende Blutbeteiligung bereits im Stadium IV sein. Voraussetzung f\u00fcr die Kategorisierung als viszerale Beteiligung (IVB; . Tab. 3.4) ist die Dokumentation eines einzigen befallenen Organs au\u00dferhalb von Haut, Lymphknoten oder Blut. Die ISCL/EORTC definiert dabei eine durch bildgebende Verfahren diagnostizierte Splenomegalie als viszerale Beteiligung auch ohne bioptische Sicherung. Der Verdacht einer Beteiligung weiterer Organe (insbesondere Leber, Lunge) sollte dagegen vor einer M-Kategorisierung entsprechend bioptisch gesichert werden. In zuk\u00fcnftigen Erhebungen und Studien sollte diese \u00fcberarbeitete Stadieneinteilung Anwendung finden. Die stadiengerechte Therapie ist in den aktuellen Leitlinien ber\u00fccksichtigt (. Tab. 3.5; Trautinger et al. 2006; Stadler et al. 2012). Au\u00dfer der allogenen Stammzelltransplantation ist keiner der Therapieans\u00e4tze kurativ, zum Teil k\u00f6nnen jedoch lang anhaltende Remissionen erreicht werden. Prinzipiell richtet sich die Therapie nach dem Stadium der Erkrankung, d. h. unter Ber\u00fccksichtigung der Ausdehnung und der Art . Tab. 3.3 Histopathologische Stadieneinteilung der Lymphknoten bei MF/SS",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "). IFN-\u03b1 (9 Mio. I.E. 3\u00d7 pro Woche s.c.) in Kombination mit PUVA ist wirksamer als IFN-\u03b1 in Kombination mit Acitretin (Neotigason \u00ae , Acicutan \u00ae ; Rate kompletter Remission 70% versus 38,1%; Stadler et al. 1998). Die Kombination von MTX mit IFN-\u03b1, nicht jedoch mit Retinoiden, scheint die Ansprechrate zu verbessern",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Kap. 3.1.10.12) ist aus dem humanen IL-2-Protein und Anteilen des Diphtherietoxins zusammengesetzt. Es f\u00fchrt \u00fcber den CD25-Rezeptor mit Freisetzung von Diftitox zur Zerst\u00f6rung von T-Lymphozyten. Die Nebenwirkungen sind teilweise erheblich. Bexaroten erh\u00f6ht die Empfindlichkeit des IL-2-Rezeptors gegen\u00fcber Denileukin diftitox. In den USA hat Ontak \u00ae die Zulassung f\u00fcr therapierefrakt\u00e4re CTCL erhalten, in Europa ist es dagegen nicht zugelassen und gegenw\u00e4rtig nicht verf\u00fcgbar. Es wird in einer Dosierung von 9 bzw. 18 \u00b5g/kg KG/d i.v. f\u00fcr 5 Tage mit Wiederholung alle 3 Wochen eingesetzt. Unter 8-14 mg wurde \u00fcber Ansprechraten von 30-50% berichtet (Olsen et al. 2001), kombiniert mit Bexaroten in einer Phase-I-Studie \u00fcber Ansprechraten von 67%",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "Abb. 3.2a) und indurierten Plaques (seltener Tumoren), insbesondere an Kopf und Hals. In vielen F\u00e4llen kommt es zur muzin\u00f6sen Degeneration des Haarfollikels (Mucinosis follicularis), h\u00e4ufig begleitet von einem Verlust der Behaarung (Alopezie der Augenbrauen als charakteristisches Merkmal) (. Abb. 3.2b). Der Juckreiz ist h\u00e4ufig stark ausgepr\u00e4gt und gilt als guter Parameter bei Krankheitsprogression. Bakterielle Superinfektionen sind h\u00e4ufig. Durch den tiefen follikul\u00e4ren Befall sind oberfl\u00e4chliche Therapien meist nicht effektiv. Variante der MF mit initialen poikilodermischen plattenartigen Infiltraten (. Abb. 3.2d). Abb. 3.2a-d Sonderformen der Mycosis fungoides. a Follikulotrope Mycosis fungoides. b Mucinosis follicularis mit Alopezie der Augenbrauen. c Pagetoide Retikulose. d Granulomatous slack skin (elastolytisches T-Zell-Lymphom)",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "Sehr selten. Betroffen sind ausschlie\u00dflich Erwachsene, meist \u00e4ltere Menschen in der 6. und 7. Lebensdekade. Winkelmann-Schema) hat sich die Pulstherapie nach dem Knospe-Schema . Abb. 3.3a-c S\u00e9zary-Syndrom. a Erythrodermie. b Palmoplantare Hyperkeratosen. c Alopezie",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "Diffuses, nicht epidermotropes Infiltrat, welches die gesamte Dermis umfasst, mit gro\u00dfen CD30 + -anaplastischen Zellen.Meist aktivierter CD4 + -T-Zell-Ph\u00e4notyp mit mehrheitlicher Expression des CD30-Antigens . Tab. 3.6 Therapieempfehlung beim S\u00e9zary-Syndrom (adaptiert nachStadler et al. 2008)",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "Chronische und Smoldering-Formen sind meist auf die Haut beschr\u00e4nkt und haben einen protrahierten Verlauf, beim akuten und Lymphom-Typ ist das mittlere \u00dcberleben 2 Wochen bis 1 Jahr.",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": ". Tab. 3.7 Therapieempfehlungen bei CD30 + -lymphoproliferativen Erkrankungen den subkutanen Lymphomen mit einem \u03b3/\u03b4-Ph\u00e4notyp eine gute Prognose. Vor der Unterscheidung zwischen dem \u03b1/\u03b2-und \u03b3/\u03b4-Ph\u00e4 notyp waren subkutane pannikulitisartige TCL als aggressive Lymphome definiert.Subkutane, pannikulitisartige dichte Infiltrate von pleomorphen zytotoxischen T-Zellen und Makrophagen. Epidermis und Dermis sind typischerweise nicht betroffen. CD3 + , CD4 -, CD8 + , CD30 -, CD45RO + , CD56 -. Bei lokalisierten L\u00e4sionen Exzision oder Radiotherapie, bei multiplen L\u00e4sionen Steroide bzw. Cyclosporin p.o., Methotrexat p.o. oder IFN-\u03b1 s.c.. Viele der Patienten k\u00f6nnen Studien zufolge \u00fcber einen l\u00e4ngeren Zeitraum mit systemischen Kortikosteroiden kontrolliert werden. Nur in seltenen F\u00e4llen eines HPS ist ggf. eine Doxorubicin-basierte Chemotherapie zu erw\u00e4gen (Go u. Wester 2004; Rezania et al. 2007).",
            "latex": null,
            "type": "table"
        },
        "TABREF10": {
            "text": "Das Lymphom geht von NK-Zellen oder zytotoxischen T-Zellen aus. Betroffen sind meist Erwachsene aus Asien, Zentral-und S\u00fcdamerika. Fast immer ist eine Ebstein-Barr-Virus-Infektion assoziiert. Andere T-Zell-Lymphome sind dagegen EBV-negativ, w\u00e4hrend B-Zell-Hodgkin-und Non-Hodgkin-(Burkitt-)Lymphome ebenfalls EBV-assoziiert sind.Neben einem destruktiv wachsenden Tumor im Gesicht (Nasenh\u00f6hle, Nasopharynx) zeigen sich multiple ulzerierende Plaques und Tumoren an der Haut, insbesondere an oberem Stamm und Extremit\u00e4ten. Die Haut kann prim\u00e4r oder sekund\u00e4r befallen sein. Der Verlauf ist sehr aggressiv mit Fieber, Gewichtsverlust und extrakutaner Ausbreitung.Medianes \u00dcberleben <12 Monate.Meist EBV + , dichte Infiltrate aus kleinen, mittelgro\u00dfen und gro\u00dfen Lymphozyten in der Dermis und Subkutis, Epidermotropismus m\u00f6glich. Gef\u00e4\u00dfdestruktion und Nekrosenbildung.",
            "latex": null,
            "type": "table"
        },
        "TABREF11": {
            "text": "Betroffen sind meist \u00e4ltere Erwachsene (durchschnittliches Manifestationsalter 53 Jahre).Mediane \u00dcberlebenszeit von <3 Jahren.Die Tumorzellen sind CD2 -, CD3 + , CD4 -, CD5 -, CD8 + mit Expression von Granzyme, Perforin und TIA-1.",
            "latex": null,
            "type": "table"
        },
        "TABREF12": {
            "text": "Meist an den Extremit\u00e4ten (Arme) auftretende disseminierte oft ulzerierte Plaques und/oder Knoten. Schleimhautbeteiligung und extrakutane Manifestationen (Leber, Lunge, Niere, ZNS) sind h\u00e4ufig, Beteiligung von Lymphknoten, Milz oder Knochenmark ist selten. Aggressives klinisches Verhalten. In 50% der F\u00e4lle h\u00e4mophagozytisches Syndrom (HPS) mit schweren St\u00f6rungen des Allgemeinbefindens, Fiebersch\u00fcben, Hepatosplenomegalie und Leukopenie bis Panzytopenie.Gew\u00f6hnlich charakterisiert als CD2 + , CD3 + , CD4 -, CD5 -, CD8 -, CD56 + , mit in allen F\u00e4llen Expression zytotoxischer Proteine, wie z. B. Granzyme, Perforin, TIA-1, und dadurch bedingter epidermaler Beteiligung mit Ulzeration.Meist einzelne nur langsam wachsende Plaques oder Knoten, insbesondere im Gesicht, an Hals und oberem Stamm.Dichte, diffuse oder knotige Infiltrate von kleinen bis mittelgro\u00dfen pleomorphen T-Zellen in der Dermis bis in die Subkutis reichend. Epidermotropismus m\u00f6glich.Die Tumorzellen sind CD3 + , CD4 + , CD8 -, CD30 -, zytotoxische Proteine werden nicht exprimiert.Exzision einzelner L\u00e4sionen, ggf. in Kombination mit lokaler Radiotherapie, bei multifokalem Geschehen in seltenen F\u00e4llen Cyclophosphamid Monotherapie oder IFN-\u03b1 (von den Driesch u.Coors et al. 2002). Eine bioptische Sicherung eines Lymphknotens sollte bei palpablen bzw. sonographisch abnormalen peripheren Lymphknoten zur genauen Stadieneinteilung stets erfolgen(Olsen et al. 2007). Die ISCL/EORTC empfiehlt dabei die Exzisionsbiopsie, da die Feinnadelbiopsie nicht geeignet ist, die f\u00fcr die N-Stadieneinteilung wesentliche nodale Architektur histopathologisch zu beurteilen. Hierbei sollte der gr\u00f6\u00dfte periphere Lymphknoten, der ein betroffenes Hautareal drainiert, und/oder ein Lymphknoten mit intensivem Uptake im FDG-PET exzidiert werden. Bei mehreren auff\u00e4lligen Lymphknoten gilt die Priorit\u00e4t: zervikal > axill\u00e4r > inguinal, da zervikale Lymphknoten eine h\u00f6here Wahrscheinlichkeit haben, einen Lymphombefall zu zeigen, als andere Regionen. Die Durchf\u00fchrung einer Knochenmarksbiopsie bei Patienten mit MF/SS wird im Fall einer B2-Blutbeteiligung (hohe Tumorlast, \u2265100/\u00b5l S\u00e9zary-Zellen, positiver Klon) oder auff\u00e4lligen Blutbefunden empfohlen. Bei aggressiven CTCL (MF im Tumorstadium, erythrodermische MF, S\u00e9zary-Syndrom, \u03b3/\u03b4-T-Zell-Lymphom, aggressives CD8 + -T-Zell-Lymphom) empfiehlt sich prim\u00e4r die Computertomographie (CT-Thorax/Abdomen) zur Beurteilung einer Systembeteiligung. Voraussetzung f\u00fcr die Kategorisierung als viszerale Beteiligung (Stadium IVB) ist die Dokumentation zumindest eines einzigen befallenen Organs au\u00dferhalb von Haut, Lymphknoten oder Blut. W\u00e4hrend eine allein durch bildgebende Verfahren diagnostizierte Splenomegalie bereits als viszerale Beteiligung auch ohne bioptische Sicherung gilt, sollte der Verdacht einer Beteiligung weiterer Organe vor einer M-Kategorisierung entsprechend bioptisch gesichert werden. PUVA (Psoralen + UVA) j Anwendung Je nach Ausdehnung/Stadium: Stamm/Extremit\u00e4ten: Bade-PUVA; Gesichtsbeteiligung: systemische PUVA; palmoplantar: Creme-oder Pinsel-PUVA/Bade-PUVA. Leukozyten und damit einen Zellzyklus-Arrest und Apoptose. Nach Phagozytose der Leukozyten kommt es \u00fcber dendritische Zellen (DCs) zur Induktion zellul\u00e4rer Immunreaktionen gegen apoptotische Tumorzellen (Berger et al. 2001), so dass die ECP hier als aktive spezifische Immuntherapie wirkt. Prim\u00e4re Erythrodermie . Tab. 3.9 PUVA-Energiedichte f\u00fcr Hauttyp I, II. Bei Hauttyp III und IV kann individuell angepasst schneller gesteigert werden \u00dcbelkeit, Diarrh\u00f6 . Tab. 3.10 Typische Nebenwirkungen von Isotretinoin/Acitretin Leucovorin \u00ae ) 15 mg i.v. alle 6h \u00fcber 72h). 58% bei CTCL (CR 41%; Zackheim et al. 1996). Infertilit\u00e4t (ovariell, z. T. permanent) 5 Zweitmalignome (AML) Bifunktionelles Alkylans. In niedriger Dosis immunstimulierend (Induktion von CD4 + -T-Helfer-Zellen; Schmoll et al. 2006, und m\u00f6glicherweise Elimination von regulatorischen T-Zellen), in h\u00f6herer Dosierung immunsuppressiv (Autoimmunerkrankungen). Lungenfibrose, interstitielle Pneumonie . Tab. 3.15 Typische Nebenwirkungen von Cyclophosphamid",
            "latex": null,
            "type": "table"
        },
        "TABREF15": {
            "text": ").Knotige bis diffuse Infiltrate, die von der unauff\u00e4lligen Epidermis durch eine schmale Zone weitgehend regelhafter Dermis abgesetzt sind, und h\u00e4ufig bis in das subkutane Fettgewebe hineinreichen. Follikul\u00e4rer Aufbau der Infiltrate aus einer Mischung vieler gro\u00dfer oft mehrkerniger Zentrozyten, wenigen Zentroblasten und vielen reaktiven T-Zellen, deren Zahl in sp\u00e4teren Stadien abnimmt. Ausgepr\u00e4gte Stromareaktion.",
            "latex": null,
            "type": "table"
        },
        "TABREF17": {
            "text": "-Jahres-\u00dcberlebensrate 50%. Dabei hat der Beintyp eine schlechtere Prognose als prim\u00e4r kutane diffus-gro\u00dfzellige Lymphome anderer Lokalisationen (5-Jahres-\u00dcberlebensrate 70%;Senff et al. 2008). Patienten mit multiplen Hautl\u00e4sionen haben eine deutlich schlechtere Prognose als Patienten mit einer solit\u00e4ren L\u00e4sion bei Diagnosestellung.Unterhalb einer unauff\u00e4lligen Epidermis zeigt sich ein gro\u00dfzelliges monomorphes dichtes Infiltrat aus variablen Anteilen von Zentro blasten und Immunoblasten, das h\u00e4ufig die gesamte Dermis einnimmt und Adnexstrukturen zerst\u00f6rt. Kleine B-Zellen fehlen und reaktive T-Zellen finden sich nur wenige, meist peri vaskul\u00e4r.",
            "latex": null,
            "type": "table"
        },
        "TABREF18": {
            "text": "Als Therapie der ersten Wahl wird die Kombinationstherapie von Rituximab mit CHOP (R-CHOP), mit oder ohne kombinierte Radiotherapie empfohlen (Richtlinien der EORTC/ ISCL;(. Tab. 3.20; Senff et al. 2008). Im Fall einer aufgrund von Alter bzw. Allgemeinzustand des Patienten nicht tolerablen Chemo therapie werden Radiotherapie oder Rituximab als Monotherapie empfohlen. Ob die Radio therapie in F\u00e4llen von kleinen solit\u00e4ren Tumoren noch als Therapie der ersten Wahl empfohlen werden kann, ist Gegenstand aktueller Diskussion. Papeln und Knoten, in der Regel am Kopf, am Oberk\u00f6rper und an den Extremit\u00e4ten. Im Gegensatz zum Beintyp und zu nodalen diffus-gro\u00dfzelligen Lymphomen ist die Prognose gut mit einer 5-Jahres-\u00dcberlebensrate von etwa 90%. In der Regel bcl-2 -(im Gegensatz zum Beintyp). Bei Lymphknoten-oder viszeralem Befall: Megavoltradiotherapie. Die Remissionsrate liegt bei 88%, die Rezidivrate bei 58% mit extrakutaner Progression in 30% der F\u00e4lle (Senff et al. 2008). 5 Bei multiplen Herden, bei Rezidiven oder bei Therapieresistenz: Liposomales Doxorubicin (Caelyx \u00ae ) 20 mg/m 2 \u00fcber 30 min i.v., alle 2-3 Wochen (6\u00d7 bis 8\u00d7). 5 Bei Rezidiven R-CHOP: CHOP in Kombination mit Rituximab (MabThera \u00ae , Truxima \u00ae) , 375 mg/m 2 i.v. jeweils an d1 nach oraler Gabe der Glukokortikoidkompo-. Tab. 3.20 Therapie der gro\u00dfzelligen CBCL vom Beintyp (nach EORTC/ISCL 2008) R-CHOP zeigte sich in verschiedenen randomisierten Studien gegen\u00fcber dem alleinigen Einsatz von CHOP bez\u00fcglich des rezidivfreien Intervalls und der Gesamt\u00fcberlebensrate signifikant \u00fcberlegen (van Oers et al. 2006; Habermann 2006).",
            "latex": null,
            "type": "table"
        },
        "TABREF19": {
            "text": "Seltene weitere Variante des diffusen gro\u00dfzelligen B-Zell-Lymphoms, bei dem sich durch Ansammlung gro\u00dfer neoplastischer B-Zellen in den Blutgef\u00e4\u00dfen r\u00f6tlich-livide, teils teleangiektatische Patches und Plaques, bevorzugt an den Beinen und am Stamm zeigen. Extrakutane Lymphommanifestationen finden sich bevorzugt in der Lunge und im zentralen Nervensystem. Es kann zu neurologischen Symptomen mit Sprachst\u00f6rungen kommen.Dilatierte Blutgef\u00e4\u00dfe in Dermis und Subkutis, angef\u00fcllt mit gro\u00dfen neoplastischen B-Zellen, die zu Gef\u00e4\u00dfokklusion f\u00fchren k\u00f6nnen.Wird das Vorliegen eines CBCL klinischerseits vermutet, sind zun\u00e4chst entsprechend repr\u00e4sentative Gewebebiopsien f\u00fcr aussagekr\u00e4ftige histologische und immunhistologische Untersuchungen erforderlich. Eine kurz gefasste \u00dcbersicht zu differenzialdiagnostisch relevanten Antik\u00f6rpern enth\u00e4lt . Tab. 3.22. Eine differenzialdiagnostische \u00dcbersicht kutaner B-Zell-Lymphome anhand der wesentlichsten immunhistologischen Marker zeigt . Tab. 3.23.Eine Klonalit\u00e4tsuntersuchung kann zur Differenzialdiagnose zwischen CBCL und Pseu dolymphomen zus\u00e4tzlich herangezogen werden(Felcht et al. 2011). Zum Ausschluss einer monoklonalen Gammopathie kann erg\u00e4nzend eine Immunelektrophorese durchgef\u00fchrt werden. Aufgrund der beschriebenen Assoziation einer Infektion mit Borrelia burgdorferi, insbesondere mit Marginalzelllymphomen, sollte diese serologisch sowie mittels PCR anhand von Hautbiopsien ausgeschlossen werden (Senff et al. 2008). Eine Knochenmarksbiopsie sollte stets bei diffus-gro\u00dfzelligen BCL erfolgen und ist bei PCMZL optional. Da bei PCFCL bei 11% der Patienten eine Knochenmarksbeteiligung gefunden wurde, die in 40% der F\u00e4lle den einzigen extrakutanen Befall darstellte, mit reduzierter. Tab. 3.21 Therapie der gro\u00dfzelligen CBCL, andere Typen Tab. 3.22 Diagnostik kutaner B-Zell-Lymphome Exzisionsbiopsie bei klinisch suspekten Lymphknoten bzw. Lymphknoten mit positivem Uptake im FDG-PET * Mantelzelllymphom: systemisches NHL-Lymphom mit LK-Vergr\u00f6\u00dferung, Splenomegalie, h\u00e4ufig Knochenmarksinfiltration aber selten kutaner Beteiligung. Klinisch aggressiver Verlauf.. Tab. 3.23 Differenzialdiagnostik kutaner B-Zell-Lymphome anhand immunhistologischer Marker Jahres-\u00dcberlebensrate, sollte eine entsprechende Abkl\u00e4rung hier ggf. durchgef\u00fchrt werden (Senff et al. 2008).Der erste zugelassene Anti-CD20 Antik\u00f6rper, mit dem auch am meisten Erfahrungen vorliegen, ist das Rituximab. Bei diesem Typ-I-Antik\u00f6rper erfolgt die B-Zelldepletion durch Apoptose und komplementabh\u00e4ngige B-Zell-Lyse. In den letzten Jahren wurden zahlreiche weitere Anti-CD20 Antik\u00f6rper zugelassen, die sich mitunter hinsichtlich ihrer komplement abh\u00e4ngigen und antik\u00f6rperabh\u00e4ngigen zellul\u00e4ren Zytotoxizit\u00e4t und Phagozytose unterscheiden. Blitzima \u00ae , Ritemvia \u00ae , Rituzena \u00ae , Rixathon \u00ae , Riximyo \u00ae und Truxima \u00ae wurden als Biosimilars zugelassen.",
            "latex": null,
            "type": "table"
        },
        "TABREF20": {
            "text": "i.v. Applikation: 375 mg/m 2 Rituximab i.v. (initial 50 mg/h, alle 30 min Steigerung um 50 mg/h bis maximal 400 mg/h, nachfolgende Infusionen dann je nach Vertr\u00e4glichkeit mit 100 mg/h beginnen) 5 Bei intraven\u00f6ser Gabe Pr\u00e4medikation mit Methylprednisolon (125 mg Urbason \u00ae ), 1000 mg Paracetamol, Antihistaminikum (Diphenhydramin/Clemastin). Ggf. Absetzen einer antihypertensiven Medikation 12 h vor Infusion. Anwendung in Notfallbereitschaft (Bereithalten von Antihistaminika, Methylprednisolon, Adrenalin). \u00dcberwachung bis 30 min nach Infusionsende 5 Monotherapie: Induktion mit 4 Infusionen 1\u00d7/Woche \u00fcber 3 Wochen, dann als Erhaltungstherapie alle 3 Wochen (4-8 Zyklen) 5 Kombination mit CHOP-Chemotherapie (R-CHOP): Gabe an d1 eines jeden CHOP-Zyklus nach der Glukokortikoidkomponente, alle 3 Wochen \u00fcber 8 Zyklen (. Tab. 3.17) 5 Bei Infusionsreaktionen/Cytokine-Release-Syndrom/Tumorlysesyndrom (7 Kap. 6): symptomatisch behandeln, nach Abklingen der Symptomatik erneute Therapie mit halber Infusionsgeschwindigkeit 5 Intratumorale Applikation (off-label): 50 mg/m 2 pro Monat. Injektion in der ersten Woche 3\u00d7/Woche 3 ml (10 mg/ml, 10-30 mg/L\u00e4sion), 1-2 Zyklen, 3-4 Wochen Intervall (Heinzerling et al. 2000; Paul et al. 2001; Kerl et al. 2006) 5 Vor Therapie: Testung auf Hepatitis B/C (bei positiver Anamnese engmaschige Kontrolle), HIV-Serologie, Tbc (Quanti feron-Test; R\u00f6ntgen-Thorax); ggf. Impfung gegen H\u00e4mophilus influenza und Pneumokokken 5 Vor jeder Infusion Bestimmung der Neutrophilenzahl Aktive und chronische Infektionen (Hepatitis B/C, HIV) 5 Herzinsuffizienz (NYHA Klasse IV; cave NYHA III), schwere, unkontrollierte Herzerkrankungen",
            "latex": null,
            "type": "table"
        },
        "TABREF21": {
            "text": "). Nebenwirkungen (. Tab. 3.24) Cytokine-Release-Syndrom (siehe auch Kapitel 6.4), vor allem bei Patienten mit hoher Tumorlast (meist 1.-2. Stunde nach Beginn der 1. Infusion): Dyspnoe, Bronchospasmen, Fieber, Sch\u00fcttelfrost, Flush, Angio\u00f6demen, Rigor; evtl. zus\u00e4tzlich Merkmale des Tumorlysesyndroms wie Hyperurik\u00e4mie, Hyperkali\u00e4mie, Hypokalz\u00e4mie, Hyperphosphat\u00e4mie, akutes Nierenversagen, Herzrhythmusst\u00f6rungen, LDH-Erh\u00f6hung (siehe auch Infektionen (Atemwege, Harnwege) 5 Progressive multifokale Leukenzephalopathie (PML, sehr selten, durch JC-Virus, ein Polyomavirus) . Tab. 3.24 Typische Nebenwirkungen von Rituximab Infusionsreaktion Pr\u00e4medikation mit Methylprednisolon (125 mg Urbason \u00ae ), 1000 mg Paracetamol, Antihistaminikum; Applikation in Notfallbereitschaft; ggf. Absetzen antihypertensiver Medikation 12 h vor Infusion Cytokine-Release-Syndrom/Tumorlysesyndrom Sofortige Unterbrechung der Infusion, nach vollst\u00e4ndiger R\u00fcckbildung aller Symptome halbe Infusionsgeschwindigkeit \u00dcberwachung neurologischer Symptome; bei Verdacht neurologische Untersuchung; Best\u00e4tigung mittels MRT und JC-Virus PCR im Liquor Keine Impfung mit Lebendimpfstoffen > Die Ansprechrate unter Rituximab the ra pie auf inaktivierte Impf stoffen kann reduziert sein. Zugelassen: CD20-positives follikul\u00e4res NHL vom B-Zell-Typ nach Vorbehandlung mit Rituximab rezidivierend oder bei Therapieresistenz Vorbehandlung mit Rituximab (250 mg/m 2 i.v. an d1, 7, 8, 9) vor Verabreichung von [ 90 Y]-radiomarkierter Zevalin \u00ae -L\u00f6sung d7, 8 und 9 (innerhalb von 4 h nach Rituximab-Infusion als Kurzinfusion \u00fcber 10 min) unter Bereithalten von Notfallmedikamenten (Adrenalin, Antihistaminika, Kortikosteroiden) 5 Empfohlene Radioaktivit\u00e4tsdosis bei Patienten mit >150.000 Thrombozyten/mm 3 : 15 MBq/kg KG; bei Patienten mit 100.000-150.000 Thrombozyten/mm 3 : 11 MBq/ kg KG 5 Bei mit murinen Proteinen vorbehandelten Patienten sowie nach der Anwendung von Zevalin \u00ae Bestimmung der humanen Anti-Maus-Antik\u00f6rper (HAMA) Patienten <18 Jahre, Schwangerschaft und Stillzeit 5 Keine Impfung mit Lebendimpfstoffen j Wirkung [ 90 Y]Ibritumomab-Tiuxetan ist ein mit Yttrium-90 als \u03b2-Strahler markierter rekombinanter muriner monoklonaler IgG1-Antik\u00f6rper gegen das B-Lymphozytenantigen CD20. Durch die Strahlung mit mittlerer Reichweite von ca. 5 mm k\u00f6nnen neben den Zielzellen auch benachbarte Zellen abget\u00f6tet werden. Durch Vorbehandlung mit Rituximab werden zirkulierende B-Lymphozyten entfernt, um so eine zielgerichtete Bestrahlung des Lymphomgewebes zu erm\u00f6glichen. Nach Deple tion der normalen B-Zellen normalisiert sich die B-Lymphozytenzahl im Blut nach ca. 9-12 Monaten. Ansprechrate 5 100% bei prim\u00e4r kutanen B-Zell-Lymphomen (CR 100%), mittlere Remissionsdauer 12 Monate (Maza et al. 2008) 5 83% bei follikul\u00e4rem B-Zell-NHL (CR 37%), mediane Remissionsdauer 9,4 Monate (Wiseman et al. 2002) Infusionsreaktionen (Schwindel, Husten, \u00dcbelkeit, Erbrechen, Hautausschlag, Juckreiz, Tachykardie, Fieber, Rigor) 5 Thrombozytopenie und Neutropenie (sehr h\u00e4ufig) nach 2 Wochen mit Nadir nach 8 Wochen (w\u00f6chentliche Blutbildkontrollen), darunter schwere und anhaltende Zytopenien. Kein spezifisches Antidot bekannt, supportive Ma\u00dfnahmen (Gabe von Wachstumsfaktoren) 5 Infektionen (sehr h\u00e4ufig) bakteriell, mykotisch, viral, einschlie\u00dflich Reaktivierung latenter Viren 5 Blutungen bei Thrombozytopenie 5 Nausea/Erbrechen, Schwindel und Dyspnoe, abdominelle Schmerzen, Arthralgie, periphere \u00d6deme, Stevens-Johnson-Syndrom 5 Zweitmalignome (myelodysplastisches Syndrom, AML) Teratogen (wirksame Empf\u00e4ngnisverh\u00fctung bis 12 Monate nach Applikation) Ibrutinib (Imbruvica \u00ae ) Gleichzeitige Gabe von CYP3A4-Inhibitoren j Wirkung Bruton Tyrosin-Kinase (BTK)-Inhibitor. Die BTK ist ein Schl\u00fcsselmolek\u00fcl im Signalweg des B-Zell Rezeptors.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "j TherapieAufgrund der \u00fcberwiegend guten Prognose sind lokale Therapiema\u00dfnahmen ausreichend, bei kleineren L\u00e4sionen die chirurgische Exzision, bei gr\u00f6\u00dferen Radiotherapie (20-30 Gy) mit 2-3 Sitzungen pro Woche \u00e0 2-4 Gy (Zenahlik et al. 2000; Piccinno et al. 2003) (. Tab. 3.19) . Hierdurch wurde in nahezu allen F\u00e4llen eine komplette Remission erreicht, in ca. 30-45% kam es jedoch zum Rezidiv (Senff et al. 2008) .Alternativ werden intral\u00e4sionale Injektionen von Interferon-\u03b1 (3\u00d7 3 Mio. I.E. pro Woche) empfohlen (komplette Remission nach 3-20 Wochen) oder die Anwendung von Rituximab (MabThera \u00ae , Truxima \u00ae ), einem gegen das B-Zellantigen CD20 gerichteten humanisierten Antik\u00f6rper (daher nur bei histologisch nachgewiesener CD20-Expression einsetzen; Senff et al. 2008) . In der Monotherapie werden 375 mg/m 2 1\u00d7 w\u00f6chentlich i.v., 4-mal \u00fcber einen Zeitraum von 4-8 Wochen empfohlen. Auch eine intral\u00e4sionale Therapie ist hiermit m\u00f6glich, wobei nur 20% der systemisch notwendigen Dosis eingesetzt wird Paul et al. 2001; Kerl et al. 2006) .Da sich in einigen F\u00e4llen von prim\u00e4r kutanen B-Zell-Lymphomen, speziell bei Marginalzonenlymphomen, mittels PCR-Analyse Borrelien-DNA nachweisen l\u00e4sst Goodlad et al. 2000) , wird initial eine Behandlung mit einem Breitspektrumantibiotikum (Doxycyclin mit 2\u00d7100 mg/d p.o. \u00fcber 3 Wochen) empfohlen, auch wenn die Effizienz f\u00fcr das follikul\u00e4re Lymphom unzureichend dokumentiert ist (Kutting et al. 1997 ).",
            "cite_spans": [
                {
                    "start": 218,
                    "end": 240,
                    "text": "(Zenahlik et al. 2000;",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 241,
                    "end": 262,
                    "text": "Piccinno et al. 2003)",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 263,
                    "end": 276,
                    "text": "(. Tab. 3.19)",
                    "ref_id": null
                },
                {
                    "start": 385,
                    "end": 412,
                    "text": "Rezidiv (Senff et al. 2008)",
                    "ref_id": null
                },
                {
                    "start": 754,
                    "end": 772,
                    "text": "Senff et al. 2008)",
                    "ref_id": null
                },
                {
                    "start": 1004,
                    "end": 1021,
                    "text": "Paul et al. 2001;",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 1022,
                    "end": 1039,
                    "text": "Kerl et al. 2006)",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1192,
                    "end": 1212,
                    "text": "Goodlad et al. 2000)",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 1420,
                    "end": 1440,
                    "text": "(Kutting et al. 1997",
                    "ref_id": "BIBREF54"
                }
            ],
            "ref_spans": [],
            "section": "annex"
        },
        {
            "text": "= primary cutaneous marginal zone lymphoma (PCMZL). Multiple kleine (<3 cm) r\u00f6tliche bis violette Papeln, Plaques und Knoten mit einem erythemat\u00f6sen Hof, ohne epidermale Beteiligung und ohne Ulzeration, bevorzugt an Stamm und Oberarmen (. Abb. 3.7). H\u00e4ufig multifokales Wachstum und Rezidivneigung, extrakutaner Befall ist jedoch sehr selten (8,5%). Die Entwicklung einer Anetodermie in spontan abheilenden L\u00e4sionen wurde beschrieben. In Europa wurde durch den Nachweis von Borrelien-DNA in entsprechenden Hautl\u00e4sionen ein m\u00f6glicher Zusammenhang von Marginalzonenlymphomen mit einer Infektion mit Borrelia burgdorferi beschrieben, nicht jedoch in USA und Asien Goodlad et al. 2000; Senff et al. 2008 Infiltration der Dermis und manchmal Subkutis, ohne Epidermotropismus und im Gegensatz zu NK-/T-Zell-Lymphomen ohne Nekrose, ohne Entz\u00fcndungszellen und ohne Gef\u00e4\u00dfinvasion. Es zeigen sich monomorphe mittelgro\u00dfe mononukle\u00e4re Zellen mit kaum sichtbaren Nukleoli, \u00e4hnlich Lymphoblasten oder Myeloblasten.j ImmunhistologieDie Tumorzellen zeigen einen CD3 -, CD4 + , CD8 -, CD43 + , CD56 + , CD45RA + -Ph\u00e4notyp, sind variabel positiv f\u00fcr CD68 und TdT (terminale Deoxynukleotidyl-Transferase) und exprimieren zus\u00e4tzlich CD123 (Interleukin-3\u03b1-Rezeptor), TCL-1 (T-cell-leukemia-1-antigen), CLA (cutaneous lymphocyte associated antigen) und BDCA-2 (blood dendritic cell antigen, CD303) als Marker plasmozytoider dendritischer Zellen (Assaf et al. 2007b; Pe trella et al. 2002; Niakosari et al. 2007 ). Die Tumorzellen sind negativ f\u00fcr CD3, CD8, CD20, CD79, Myeloperoxidase (MPO), CD34 und CD10. Eine myelomonozyt\u00e4re Leuk\u00e4mie sollte ausgeschlossen werden (CD3 + , MPO + ), da CD4 + / CD56 + -Hautmanifestationen hiermit oft assoziiert sind.j Therapie Die Behandlung sollte dem Therapieregime einer akuten Leuk\u00e4mie entsprechen, in Zusammenarbeit mit der H\u00e4matoonkologie. Es wird eine anthrazyklinbasierte Kombinationschemotherapie, ggf. in Kombination mit Strahlentherapie, empfohlen. Da nahezu alle F\u00e4lle \u00e4u\u00dferst therapierefrakt\u00e4r sind und der gr\u00f6\u00dfte Teil der Patienten innerhalb eines Jahres verstirbt, ist eine fr\u00fchzeitige allogene Knochenmarkstransplantation zu erw\u00e4gen (Bekkenk et al. 2003 (Bekkenk et al. , 2004 Berti et al. 1999; Assaf et al. 2007b ).",
            "cite_spans": [
                {
                    "start": 661,
                    "end": 681,
                    "text": "Goodlad et al. 2000;",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 682,
                    "end": 699,
                    "text": "Senff et al. 2008",
                    "ref_id": null
                },
                {
                    "start": 1423,
                    "end": 1443,
                    "text": "(Assaf et al. 2007b;",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1444,
                    "end": 1466,
                    "text": "Pe trella et al. 2002;",
                    "ref_id": null
                },
                {
                    "start": 1467,
                    "end": 1488,
                    "text": "Niakosari et al. 2007",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 2162,
                    "end": 2182,
                    "text": "(Bekkenk et al. 2003",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 2183,
                    "end": 2205,
                    "text": "(Bekkenk et al. , 2004",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 2206,
                    "end": 2224,
                    "text": "Berti et al. 1999;",
                    "ref_id": null
                },
                {
                    "start": 2225,
                    "end": 2243,
                    "text": "Assaf et al. 2007b",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Marginalzonenlymphom"
        }
    ]
}